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Summary 
 
Pyrrolidine Dithiocarbamate (PDTC) is a metal chelating compound with antioxidant 
properties. PDTC is a copper and zinc ionophore and exerts many different effects in 
biological systems. It is able to inhibit the activation of NFκB, the replication of 
picornaviruses and proteasome-dependent proteolysis. PDTC exhibits pro- as well as 
anti-apoptotic effects depending on the model system used. 
Apoptosis is a kind of programmed cell-death and is a very important mechanism in 
multicellular organisms to remove damaged or unwanted cells. The initiation of this 
cellular suicide program involves a lot of different signalling events which converge at 
the level of caspases. Pre-existing data of our laboratory suggest that PDTC act as 
an inhibitor of apoptosis. 
The aim of this project was to find out which steps of the apoptotic pathway are 
affected by PDTC. It was assumed that the property of PDTC to act as zinc 
ionophore and subsequently increasing intracellular zinc levels, play an important 
role in inhibiting of apoptosis. This was supposed because zinc is known to inhibit 
caspases, which are proteases and activated during apoptosis. Further zinc is known 
to activate the PI3K/Akt pathway which provides survival-signals for the cell. 
To answer the question how the anti-apoptotic effect of PDTC is achieved, HeLa 
cells, caspase-3 deficient MCF-7 as well as caspase-3 overexpressing MCF-7-cas3+ 
cells were used. Apoptosis was induced with Actinomycin D or Puromycin. These two 
substances were chosen due to the well known mode of action. Subsequently 
different hallmarks of apoptosis were analysed. 
Herein it is shown that PDTC is able to inhibit cell death in HeLa, MCF-7 and MCF-7-
cas3+ cells. This effect was abolished in the presence of the metal chelator EDTA in 
HeLa cells. This means that the anti-apoptotic property of PDTC depends on the 
presence of certain metal ions. The release of cytochrome c from mitochondria, 
which is characteristic for apoptosis, was delayed in the presence of PDTC. 
The effects of PDTC on caspases were studied by using a caspase 3/7 assay, a cell-
free system and the MCF-7 cell line. Herein PDTC seems not to act mainly on the 
level of caspases. Interestingly, the PI3K/Akt pathway is induced due to PDTC-
treatment as demonstrated by western blot analysis. But inhibition of this pathway did 
not abolish the anti-apoptotic property of PDTC. In general the results suggest that 
PDTC acts mainly on pre- and/or mitochondrial stages of apoptosis. 
 4
 
Zusammenfassung 
 
Pyrrolidine Dithiocarbamat (PDTC) ist eine Substanz die Komplexe mit Metallen 
bilden kann und anti-oxidative Eigenschaften besitzt. PDTC ist ein Kupfer- und Zink-
Ionophor und bewirkt eine Vielzahl von Effekten in biologischen Systemen. Es 
inhibiert die Aktivierung von NFκB, die Replikation von Picornaviren und die 
Proteasome-abhängige Proteolyse. PDTC zeigt pro- als auch anti-apoptotische 
Wirkung, abhängig vom verwendeten Modellsystem. 
Apoptose ist eine Form des programmierten Zelltods und ein wichtiger Mechanismus 
in multi-zellulären Organismen um beschädigte oder nicht mehr benötigte Zellen zu 
entfernen. Die Initiation dieses zellulären Selbstmordprogramms involviert eine 
Vielzahl von Signalwegen, die bei den Caspasen zusammenlaufen. Caspasen sind 
Proteasen, die im Laufe der Apoptose aktiviert werden. Bereits vorhandene Daten 
aus unserem Labor legten eine inhibitorische Wirkung von PDTC auf Apoptose nahe. 
 
Das Ziel dieses Projekts war es herauszufinden, welche Stufen der Apoptose durch 
PDTC beeinflusst werden. Es wurde angenommen, dass die Eigenschaft von PDTC 
als Zink-Ionophor zu wirken und somit die intrazelluläre Konzentration von Zink zu 
erhöhen, eine wichtige Rolle bei der Inhibierung der Apoptose spielt. Der Grund dafür 
war, dass die Inhibierung von Caspasen durch Zink bereits beschrieben wurde. 
Weiters ist Zink in der Lage den PI3K/Akt Pathway zu aktivieren, der 
Überlebenssignale für die Zelle liefert. 
Um die Frage zu beantworten, wie der anti-apoptoische Effekt von PDTC zu stande 
kommt, wurden HeLa Zellen sowie Caspase-3 defiziente MCF-7 und Caspase-3 
überexpremierende MCF-7-cas3+ Zellen verwendet. Apoptose wurde in diesem 
Zellsystem induziert mit Actinomycin D oder Puromycin. Diese beiden Substanzen 
wurden aufgrund ihres bekannten Wirkungsmechanismus verwendet. Verschiedene 
Kennzeichen der Apoptose wurden anschließend untersucht. 
In diesem Projekt wird gezeigt, dass PDTC eine anti-apoptotische Wirkung in HeLa, 
MCF-7 und MCF-7-cas3+ Zellen hat. Dieser Effekt wird durch EDTA, einem 
Komplexbildner, in HeLa Zellen aufgehoben. Dies bedeudet, dass der anti-
apoptotische Effekt von PDTC von Metallionen abhängig ist. 
Die Freisetzung von cytochrom c aus den Mitochondrien ist charakteristisch für 
Apoptose und wird durch PDTC verzögert. Die Effekte von PDTC auf Caspasen 
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wurden untersucht mittels Caspase 3/7 assays, einem zellfreien System sowie der 
Zelllinie MCF-7. In diesem Projekt wird gezeigt, dass PDTC nicht hauptsächlich auf 
Caspasen wirkt. 
Interessanterweise wird der PI3K/Akt pathway durch PDTC aktiviert, wie mittels 
Western Blot Analysen gezeigt wird. Allerdings hebt die Inhibierung dieses Pathways 
nicht die anti-apoptotische Wirkung von PDTC auf. Die Ergebnisse dieses Projekts 
lassen auf einen pre- und/oder mitochondriellen Effekt von PDTC schließen. 
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Introduction 
 
 
I.1 The concept of cell death 
 
In general there are many possibilities how a cell can die. The way how cell death is 
achieved depends on different factors and circumstances such as cell type and 
environmental conditions. In this case environment refers to the surrounding area of 
cells in a whole organism or in cell culture. 
Basically at least three different kinds of cell death are distinguished, namely 
apoptosis, autophagy and necrosis (Fink and Cookson 2005; Galluzzi, Maiuri et al. 
2007). All of them are described in detail later in this section. 
Cell death was initially studied using the hermaphrodite Caenorhabditis elegans. It 
was found out that a significant fraction of cells generated during development die 
shortly after birth. Indeed, it is unlikely that most of them have time to perform any 
function. The resulting question is, why cells are generated and removed shortly 
afterwards. Cells die in a defined manner (programmed cell death) when they are 
produced in excess during development, already have served their purpose or if they 
are potential harmful for the organism. It is assumed that under certain circumstances 
it is simpler to use programmed cell death as a cellular suicide program than to 
generate a new cellular program that would avoid the formation of superfluous cells. 
Programmed cell death is used to refine stereotypical lineages and to produce 
sexually dimorphic structures in Caenorhabditis elegans (Donald L. Riddle 1997). 
There is evidence that some kind of cell death is of ancient origin and evolutionary 
conserved. At first view, for unicellular organism it’s not necessary to have the ability 
to undergo programmed cell death. But if they live in close proximity of each other, it 
could be an advantage (Donald L. Riddle 1997). Recently it was shown that yeast 
cells can undergo apoptosis (Buttner, Eisenberg et al. 2006). 
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I.2 Classification of cell death 
 
The process of cell death can classified according to the procedures taking place in a 
dying cell. There are three major types of cell death, namely apoptosis, autophagy 
and necrosis. Four criteria can be used to classify the type of cell death (Galluzzi, 
Maiuri et al. 2007): 
1) Morphological appearance 
2) Enzymological criteria 
3) Functional aspects: programmed vs. accidental 
4) Immunological characteristics 
 
ad 1) 
Apoptosis is the best studied kind of cell death and mainly defined by morphological 
alterations. These changes include chromatin condensation, nuclear fragmentation 
and the formation of apoptotic bodies. These vesicles are surrounded by a 
membrane and contain cytoplasmic organelles (Galluzzi, Maiuri et al. 2007). In whole 
organisms apoptotic bodies are engulfed by phagocytic cells (Fink and Cookson 
2005; Jin and El-Deiry 2005; Galluzzi, Maiuri et al. 2007). Hallmarks of apoptosis are 
the activation of certain proteases called caspases and the fragmentation of DNA 
(Lawen 2003; Jin and El-Deiry 2005). The cell death of apoptosis is described in 
detail in section I.4. It is important to mention that apoptosis can occur without these 
two properties (Galluzzi, Maiuri et al. 2007). 
During apoptosis all cellular structures and organelles are degraded rapidly. In 
contrast autophagy is a slow process. In autophagic cell death parts of the cytplasm 
are surrounded by double-membraned vacuoles and digested by lysosomal 
hydrolases (Galluzzi, Maiuri et al. 2007). 
Morphological alterations during necrosis include an increase of cell volume (oncosis) 
thus leading to the rupture of the plasma membrane. In general necrosis lacks 
biochemical markers (Galluzzi, Maiuri et al. 2007). A summary of morphological 
features of cell death is shown in Fig. 1. 
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ad 2) 
Different enzymatic processes are activated in different forms of cell death. The 
activation of caspases is associated with apoptosis. The permeabilization of the 
mitochondrial membrane plays a role in apoptosis as well as in necrosis (see I.4.2.). 
This process is considered as “point-of no return” thus committing the cell to 
undergoing cell death. It is reported that the metabolic status also can influence the 
kind of cell death. The presence of high glucose- and adenosintriphosphat (ATP)-
levels favour the execution of apoptosis. This might be due to the fact that ATP is 
required for the activation of caspases. Depletion of ATP can switch cell death to 
necrosis (Galluzzi, Maiuri et al. 2007). 
 
ad 3) 
Very often the term “programmed cell death” is used as a quasi synonym for 
apoptosis. It is important to mention that necrosis can also be programmed (i.e. 
genetically predetermined). It is also suggested that a defined course of events take 
place in a necrotic cell (Galluzzi, Maiuri et al. 2007). 
 
ad 4) 
The widespread view that apoptosis is a physiological form of cell death whereas 
necrosis is the pathological form of cell death is oversimplified. In general it is true 
that apoptosis cause no inflammatory response in contrast to necrosis due to the 
release of cellular content. Some agents (for example: ionizing radiation) can induce 
a kind of cell death which is similar to apoptosis in the morphological pattern but 
accompanied by an immune response (Galluzzi, Maiuri et al. 2007). 
 
 
I.3 Comparison of apoptosis, autophagy and necrosis 
 
Three major types of cell death are described and further kinds are expected to exist 
(Fink and Cookson 2005): Apoptosis (type 1 cell death), autophagy (type 2) and 
necrosis (type 3) (Fink and Cookson 2005; Galluzzi, Maiuri et al. 2007). An overview 
of pathways leading to cell death is shown in Fig. 2.  
The kind of death stimulus influence the way of cell death which is used (Galluzzi, 
Maiuri et al. 2007). For example DNA damage leads to caspase activation and to 
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apoptosis. Starvation of nutrients usually leads to autophagic cell death and osmotic 
lysis leads to necrosis (Galluzzi, Maiuri et al. 2007).  
The morphological differences of apoptosis, autophagy and necrosis are depicted in 
Fig. 1.  
 
Fig. 1: Morphological aspects of different forms of cell death. Modified from (Galluzzi, Maiuri et al. 
2007).  
 
 
I.3.1 Apoptosis (type 1 cell death) 
 
Apoptosis is the best studied type of cell death. It is described in detail in section I.4. 
Briefly, apoptosis can be divided into an initiation-, mediation- and execution phase. 
The initiation phase transmits information from a ligand to a receptor (Riedl and 
Salvesen 2007). There are two pathways, an extrinsic and an intrinsic one which can 
be triggered by various signals. For example DNA damage leads to the activation of 
the intrinsic pathway of apoptosis (Galluzzi, Maiuri et al. 2007). The extrinsic pathway 
of apoptosis is based on the interaction of extracellular ligands to their appropriate 
receptors on the cell surface. The receptor of the intrinsic pathway is Apaf-1, a 
multidomainprotein which is described on page 17. In the effector phase biochemical 
events are executed which result in the desired cellular response (Riedl and 
Salvesen 2007).The central effectors of apoptosis are specific proteases called 
caspases. Activator caspases cleave a lot of cellular substrates leading to typical 
morphological changes. This morphological pattern is described in Fig. 1. At the end 
cells are packaged into vesicles called apoptotic bodies which are cleared by 
phagocytosis (Fig. 2) (Jin and El-Deiry 2005). The regulation of this process is very 
complex and described in detail in section I.5. 
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I.3.2 Autophagy (type 2 cell death) 
 
Autophagy is a cellular process which allows the degradation and recycling of 
macromolecules. Various kinds of stress can induce this mechanism such as 
deprivation of nutrients. Cells are able to provide nutrients for ATP synthesis by 
autophagy (Ferraro and Cecconi 2007). 
It is important to mention that autophagy is a pro- survival as well as a pro-death 
mechanism (Ferraro and Cecconi 2007). In proper style the term “autophagy” refers 
to the survival function of this mechanism and the term “autophagic death” to the pro-
death function. In this study as well as in other reviews regarding cell death 
“autophagy” means “autophagic cell death”. This is a kind of cell death which occur 
with (!) autophagy (Galluzzi, Maiuri et al. 2007). 
The autophagic pathway starts with the engulfment of cytoplasmic material in 
membrane vesicles called autophagosomes. These vesicles finally fuse with 
lysosomes in a microtubule dependent manner and the content is degraded. In vivo 
cells undergoing autophagy are phagocytized (Fig. 2) (Fink and Cookson 2005). The 
morphological appearance of autophagic cells is mentioned in Fig. 1. It is suggested 
that autophagy can act under certain conditions as substitute of apoptosis. This is the 
case when apoptosis fails. Then cells have the option to die via autophagy (Ferraro 
and Cecconi 2007). 
 
 
I.3.3 Necrosis (oncosis) (type 3 cell death) 
 
Necrosis is characterised as a passive and accidental form of cell death (Galluzzi, 
Maiuri et al. 2007). But there is evidence that necrosis could also be programmed 
(Golstein and Kroemer 2007). Necrosis can occur during development; it can be 
triggered by plasma membrane receptors and is influenced by genetic factors. 
Further necrosis can be prevented by inhibition of certain enzymes and by the 
inhibition of caspases (Golstein and Kroemer 2007).  
Oncosis is the prelethal pathway leading to cell death by cellular swelling (Fig. 2). 
This process leads to the depletion of energy stores and failure of ionic pumps in the 
plasma membrane (Fink and Cookson 2005). The gain of cell volume during oncosis 
leads to the rupture of the plasma membrane. Subsequently the cell content is 
released in an unorganized manner into the cellular environment. In vivo necrosis 
 13
causes an inflammatory response. Necrosis lacks specific biochemical markers thus 
it can be only detected by electron microscopy (Galluzzi, Maiuri et al. 2007). 
 
 
I.3.4 Pyroptosis 
 
This is a new form of cell death which is described in the literature (Fink and Cookson 
2005). This form of cell death is induced by Salmonella and Shigella infections. 
Pyroptosis is mentioned here only for the sake of completeness because it is 
depicted in Fig. 2. Until now (Sept. 07) only nine papers are published in the PubMed 
concerning this kind of cell death. 
 
 
Fig. 2: Overview of different forms of cell death. 
(Fink and Cookson 2005) 
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I.4 Apoptosis 
 
The word apoptosis derives from the Greek language and denotes “falling of leaves 
from a tree in the autumn”. In cell biology the term apoptosis describes a specific 
morphology of cell death (Lawen 2003). 
Apoptosis is important in development and tissue homeostasis of multicellular 
organisms. Throughout development more cells are produced than necessary. The 
excess of these cells might undergo apoptosis thereby contributing to the shape of 
tissues and organs. Apoptosis is a regulated process which is evolutionary conserved 
in different species. Malfunction of this regulation may lead to developmental defects, 
autoimmune diseases or cancer (Jin and El-Deiry 2005). 
 
 
I.4.1 Morphological features of apoptosis 
 
Different morphological changes can be observed during apoptosis (Fig. 1). In an 
early phase cells round up and loose their contact with their neighbours. They shrink, 
chromatin condenses and the DNA is fragmented. The nucleus and the plasma 
membrane become convoluted and form blebs. Finally the cell falls apart in 
membrane-encapsulated apoptotic bodies. These spheres are engulfed by 
macrophages of the surrounding tissue thus avoiding any inflammatory response 
(Lawen 2003; Jin and El-Deiry 2005). 
 
 
I.4.2 Pathways of apoptosis 
 
A variety of different signals can initiate the suicide program of a cell. There are two 
pathways responsible for apoptosis, an extrinsic- and an intrinsic- one. The extrinsic 
pathway signals due to the binding of external death inducing ligands to their 
appropriate receptors (for example: Fas:FasL). The intrinsic pathway is activated as 
consequence of DNA damage induced by radiation or chemicals as well as by growth 
factor withdrawal (Jin and El-Deiry 2005). 
 
 15
Fig. 3: Extrinsic- and intrinsic pathway of apoptosis. 
(MacFarlane and Williams 2004) 
 
a) Extrinsic Pathway 
 
The extrinsic pathway is activated as a consequence of death-receptor/ligand 
interactions (Fig. 3). These are mainly TNF-TNFR1 and FasL-Fas. The tumor 
necrosis factor receptor (TNFR) superfamily consists of death receptors with different 
functions. The presence of cysteine rich domains in those receptors is responsible for 
ligand binding. Death receptors contain a cytosolic death domain. After ligand binding 
different intracellular adapter molecules (for example: FADD [fas associated death 
domain]) are recruited to the appropriate death receptor. This depends on the kind of 
receptor. The binding of adaptor proteins to the death receptor is mediated by the 
homophilic interaction of death domains. Further a signalling complex called DISC 
(death inducing signalling complex) is formed and caspase 8 or 10 is recruited 
depending on the receptor. The extrinsic as well as the intrinsic pathway converge at 
the level of caspases (Lawen 2003; Jin and El-Deiry 2005). The activation of 
caspases is described in section I.4.3. 
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b) Intrinsic Pathway 
 
The intrinsic pathway is initiated inside the cell. Signals leading to the activation of 
this pathway are different forms of extra- and intracellular stress. For example, 
oxidative stress, radiation, withdrawal of growth factors or treatment with 
chemotherapeutic drugs (Jin and El-Deiry 2005). The Akt pathway which is activated 
by extracellular growth factors can regulate apoptosis (Alberts, Johnson et al. 2002; 
Jin and El-Deiry 2005) as depicted in Fig. 4. In addition there are many other 
signalling pathways in cells which regulate cell proliferation. 
The most important events in the intrinsic pathway of apoptosis are taking place at 
the mitochondria. The key event is the mitochondrial outer membrane 
permeabilization (MOMP). 
Responsible for this process are proteins of the Bcl-2 family. All members have at 
least one Bcl-2 homology domain in common. The Bcl-2 family is divided into pro- 
and anti-apoptotic members. The susceptibility of a cell to undergo apoptosis 
depends on the ratio of these two groups. The regulation of apoptosis is described in 
detail in section I.5. Bax and Bak are pro-apoptotic members of the Bcl-2 family. 
These two proteins form oligomers and insert into the outer mitochondrial membrane 
(OMM) which leads to the release of cytochrome c and other proteins (Lawen 2003; 
Jin and El-Deiry 2005).  
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Fig. 4: Details of the intrinsic pathway of apoptosis. 
(Jin and El-Deiry 2005) 
 
Cytochrome c (cyt c) plays an important role in apoptosis as well as in the electron 
transport chain. When released into the cytosol cyt c binds Apaf-1, a scaffold protein, 
which leads in the presence of ATP/dATP to the formation of a complex called the 
apoptosome. Caspase-9 is recruited to the apoptosome and thus activated due to 
oligomerization (Jin and El-Deiry 2005). The apoptosome is an approx. 1 MDa 
complex and composed of seven Apaf-1, seven cyt c, seven (d)ATP and seven 
procaspase 9 molecules (Lawen 2003). 
 
The apoptosome acts as a soluble receptor. It is thought that the formation of this 
signalling platform is a multistep process. Apaf-1 plays a key role in this process (Fig. 
5). This multidomainprotein consists of an N-terminal caspase-recruitment domain 
(CARD), a nucleotide binding domain (NB-ARC) and a string of WD40 repeats in the 
C-terminus. The CARD domain is responsible for the recruitment of procaspase-9 by 
homotypic interaction. The function of the WD40 repeats is the binding of 
cytochrome c which is released from the mitochondria. The nucleotide binding 
domain contains an ATPase domain and is responsible for (d)ATP binding. Apaf-1 
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exists as a monomer in the absence of an apoptotic signal and contains a (d)ATP 
molecule in its centre. The crucial event of apoptosome formation is the binding of 
cytochrome c to the WD40 repeats. Afterwards the bound nucleotide is hydrolysed. 
Subsequently Apaf-1 exists in a semi-opened conformation. The NB-ARC region and 
the CARD domain of Apaf-1 remain inactive thus no recruitment of caspase-9 can 
occur. To enable the formation of the apoptosome Apaf-1 must undergo massive 
conformational changes (Riedl and Salvesen 2007). 
 
Fig. 5: Mechanism of apoptosome formation. Apaf-1 composed of CARD, WD40 and NB-ARC 
domains (left) binds cytochrome c when released from mitochondria. This leads to a semi-opened 
conformation of Apaf-1. (d)ATP exchange leads to formation of the apoptosome which in turn recruits 
procaspase-9. (Riedl and Salvesen 2007) 
 
 
A second group of proteins released from the mitochondria are inhibitor of apoptosis 
(IAPs) antagonists. IAPs are cytosolic proteins and a kind of brake for apoptosis. 
IAPs are described in detail in section I.5.2. These proteins are able to inhibit active 
caspases. IAP antagonists function as competitive inhibitors of IAPs thus neutralizing 
their purpose. (Fan, Han et al. 2005) 
 
 
I.4.3 Caspases 
 
Caspases are aspartate-specific cysteine proteases. They belong to the interleukin-
1ß-converting enzyme family. Fourteen different caspases are identified. All 
caspases have a pentapeptide active-site in common. The precursors of caspases 
are called procaspases and are zymogens. This means that they are activated by 
proteolytic cleavage. All caspases are able to autoactivate themselves as well as 
activating other caspases (Fan, Han et al. 2005). 
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Caspases are divided into three subfamilies: Apoptosis activators-, Apoptosis 
executioner- and inflammatory mediator caspases. Caspases 2, 8 and 10 belong to 
the first group. Apoptosis executioner caspases are caspase 3, 6 and 7. Caspase 1, 
4, 5, and 11 belong to the third group of caspases mentioned. Caspases contain a 
protease domain which can be subdivided into a large catalytic subunit and a small 
catalytic subunit. A procaspase also contain a prodomain or an N-terminal peptide of 
variable length. Initiator- and inflammatory caspases have long prodomains. A 
prodomain contains the death effector domain (DED) and the caspase recruitment 
domain (CARD). DED and CARD mediate homophilic interactions and are important 
in procaspase activation (Rupinder, Gurpreet et al. 2007). The structural comparison 
of caspases is shown in Fig. 6. 
 
Fig. 6: Structural comparison of caspases. Group I: inflammatory caspases; Group II: apoptosis 
initiator caspases; Group III: apoptosis effector caspases. 
(Rupinder, Gurpreet et al. 2007) 
 
 
To activate an initiator caspase oligomerization or induced proximity is required. Thus 
adaptor molecules are recruited to a death complex. Subsequently, conformational 
changes of these molecules enable the recruitment of procaspases due to protein-
protein interactions. The close proximity and this high local concentration of 
procaspases lead to autocatalytic activation. This mechanism is mediated by the N-
terminal CARD and DED domains. There are three different death complexes: known 
as PIDDososme, DISC and apoptosome. They differ in the recruited adaptor 
molecules and caspases (Ho and Hawkins 2005). 
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The proteolytic cleavage of procaspases at specific Asp-X bonds, which is induced 
by close proximity of these molecules lead to the maturation of caspases. During 
proteolytic cleavage the prodomain is released. Mature caspases are 
heterotetramers. This heterotetramer is composed of two heterodimers which are 
aligned in a head-to-tail configuration. Two active sites are located at opposite ends 
thus a heterotetramer contains four active sites. The catalytic machinery involves a 
cysteine sulfhydrylgroup and a histidine imidazol ring (Rupinder, Gurpreet et al. 
2007). 
Fig. 7 shows a schematic representation of this process. 
 
 
Fig. 7: Schematic representation of procaspase processing. Procaspase is cleaved at specific Asp-X 
bonds as indicated. p20: large catalytic subunit; p10: small catalytic subunit; 
(Rupinder, Gurpreet et al. 2007) 
 
 
Caspase-8 which plays an important role in the extrinsic pathway of apoptosis is able 
to induce cytochrome c release by truncation of Bid (Fig. 3 and Fig. 4). Bid is a pro-
apoptotic member of the Bcl-2 family. The truncated form of Bid (tBid) subsequently 
translocates to the mitochondria and leads to the release of cytochrome c. Thus the 
mitochondrial pathway is activated as well. This mechanism acts as an amplification 
loop for the apoptosome formation. (Ho and Hawkins 2005) Activator caspases 
activate downstream executioner caspases by proteolytic processing. 
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I.4.4 Targets of caspases 
 
Activated caspases initiate a death program by destroying key components of cellular 
infrastructure (Rupinder, Gurpreet et al. 2007). A key factor in apoptosis is caspase 
3. Procaspase-3 is activated by caspase-3, -8 and -10. Substrates of caspase-3 
include procaspase-3, -6, -9 and PARP [poly(ADP-ribose) polymerase] (Fan, Han et 
al. 2005). 
Another substrate of caspase-3 is ROCK-1 (Rho-associated kinase). The cleavage of 
ROCK-1 during apoptosis generates a truncated molecule with increased kinase 
activity. This leads to cell contraction and membrane blebbing (Creagh and Martin 
2001). 
A lot of other cellular proteins are cleaved in apoptosis due to caspase activity. For 
example nuclear lamins which are cleaved by caspase-6 (Widlak 2000). This leads to 
the characteristic morphological changes described in section I.4.1. The executioner 
caspases-6 and -7 are homologous of caspase-3. Caspase-3 and -6 are able to 
activate each other thus creating a positive feedback loop.  
PARP which is involved in DNA repair can be cleaved by all executioner caspases 
(Fan, Han et al. 2005). The function of PARP which is a nuclear enzyme is the 
addition of poly(ADP-ribose) to nuclear proteins. In the case of massive DNA damage 
the substrate of PARP, NAD (nicotinamide-dinucleotide) is depleted. Subsequently 
the ATP level decreases due to NAD synthesis. During apoptosis PARP is cleaved to 
preserve cellular ATP (Fink and Cookson 2005). The ATP level may influence the 
type of cell death. ATP is required for caspase activation. The cleavage of PARP is a 
hallmark of apoptosis and can be detected easily by western blot analysis. 
During apoptosis DNA fragmentation can occur. This event is also triggered by 
caspases. Responsible for the generation of large-scale DNA fragments is an 
endonuclease called DNA Fragmentation factor 40 (DFF40) or caspase-activated 
DNase (CAD). This is an endonuclease specific for dsDNA but not for ssDNA or 
RNA. DFF40 generates blunt ends which can be detected by TUNEL staining. DFF40 
attacks chromatin in the internucleosomal linker DNA and generates mono- as well 
as oligonucleosomal fragments. DFF40 requires the presence of Mg2+ but is inhibited 
by Zn2+. Further it is assumed that DNA breakdown during apoptosis was developed 
to prevent the transfer of potentially harmful DNA (i.e. activated oncogenes or viral 
genes). It is important to mention that apoptosis can also occur without DNA 
fragmentation (Widlak 2000). 
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Chromatin condensation takes place at terminal stages of apoptosis. This can be 
triggered by DNA fragmentation per se in the case of DFF40. It was found out that 
this process does not require ATP (Widlak 2000). 
DNA fragmentation can also be induced in a caspase-independent manner (Widlak 
2000) by AIF (apoptosis inducing factor) as depicted in Fig. 4. 
AIF is released from the mitochondria during apoptosis and translocates to the 
nucleus. AIF is a NADH oxidase and is important for optimal oxidative 
phosphorylation. In the nucleus it induces DNA fragmentation and chromatin 
condensation. The contribution of AIF to cell death depends on the cell type 
(Modjtahedi, Giordanetto et al. 2006). 
 
 
I.4.5 Caspase inhibitors 
 
The first caspase inhibitor discovered was a viral protein from cowpox virus 
designated as cytokine response modifier (CrmA). The advantage of a virus to inhibit 
caspases is an increasing of the viral replication time or preventing the generation of 
inflammatory cytokines. CrmA inhibits caspase-1 and -8 as well as caspase-10 in 
humans. CrmA acts as pseudosubstrate and binds to the active site of caspases. 
A common used caspase inhibitor is N-Benzyloxycarbonyl-Val-Ala-Asp(O-Me) 
fluoromethyl ketone, abbreviated as zVAD-fmk. This is a general cell-permeable 
caspase inhibitor (Sigma-Aldrich). zVAD-fmk is an irreversible inhibitor due to its 
fluoromethylketone moiety. It serves as a pseudosubstrate for active caspases and 
blocks their catalytical center. zVAD-fmk inhibits all caspases except caspase-2 
which is inhibited weakly (Callus and Vaux 2007). Furthermore, other inhibitors 
specific for different caspases exist. 
The use of caspase inhibitors has revealed the existence of alternative cell death 
pathways, which may function as backup cell death program for apoptosis. zVAD-fmk 
modulates the three major types of cell death in different ways. It blocks apoptotic cell 
death while sensitizing cells to necrosis. zVAD-fmk may also trigger autophagic cell 
death (Vandenabeele, Vanden Berghe et al. 2006; Rupinder, Gurpreet et al. 2007). 
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I.5 Regulation of apoptosis 
 
 
I.5.1 Upstream of mitochondria: Bcl-2 family proteins 
 
The Bcl-2 family of proteins function as “life/death switch” by integrating inter- and 
intracellular signals. The Bcl-family is divided into three different subfamilies (Adams 
and Cory 2007): 
pro-survival subfamily: Bcl-2, Bcl-XL, Bcl-x, Mcl-1, A1, Bcl-B 
Bax-like apoptotic subfamily: Bax, Bak, Bok 
BH3-only proteins: Bik, Bad, Bid, Bim, Bmf, Hrk, Noxa, Puma 
There are three Bcl-2 homology domains (BH1, BH2, BH3) which have the pro-
survival subfamily and the Bax-like apoptotic subfamily in common. BH3-only 
proteins are largely unrelated to each other as well as to the pro-survival subfamily 
except the BH3 domain. The BH domains of each pro-survival member fold into a 
globular structure with a hydrophobic groove. On this groove a BH3 domain which is 
an amphipathic alpha helix can bind. This interaction neutralizes the pro-survival 
family member. BH3-only proteins seem to act as damage sensors and direct 
antagonists of Bcl-2 pro-survival members. BH3-only proteins are activated when 
apoptosis is induced (Adams and Cory 2007). 
For example, Bim is associated with the cytoskeleton and released in response to 
apoptotic stimuli (Bouillet and Strasser 2002). Thus Bim is able to translocate to the 
mitochondria and the nucleus (Bouillet and Strasser 2002). 
Bak is an integral membrane protein on the cytosolic face of mitochondria and ER. 
Bax is largely a cytosolic protein or loosely associated with mitochondria. During 
apoptosis Bax translocates to mitochondrial membranes. Subsequently Bax and Bak 
change their conformation and form membrane-associated homo-oligomers. Further 
the mitochondrial membrane is permeabilized leading to the release of cytochrome c 
(Adams and Cory 2007; Hacker and Weber 2007).  
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I.5.2 Inhibition of caspases by IAP (inhibitor of apoptosis) 
proteins 
 
IAPs are regulatory proteins which contain several BIR (baculovirus inhibitor of 
apoptosis repeat) motifs and a RING domain. Some IAPs also contain a CARD 
(caspase recruitment domain) motif. The BIR domain enables IAPs to bind and thus 
to inhibit caspases. The RING domain allows the recruitment of ubiquitin-conjugating 
enzymes and to catalyse the transfer of ubiquitin from this enzyme to a substrate. 
Thus IAPs can target many proteins such as caspases or themselves to degradation 
by the proteasome. The best characterized IAP member is XIAP (X-linked inhibitor of 
apoptosis). XIAP binds active caspase-9 and -3 by its BIR domains. (Vaux and Silke 
2005)  
To enable the progression of apoptosis IAPs have to be inactivated. This is achieved 
by the release of IAP antagonists from mitochondria during apoptosis (Fan, Han et al. 
2005). IAP antagonists can contain an IAP binding motif (IBM). IAP antagonists 
include Smac/DIABLO and HtrA2/Omi which share an IBM in common. They 
compete directly with caspase-9 for binding to XIAP as shown in Fig. 4. (Vaux and 
Silke 2005) 
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I.6 Induction of apoptosis 
 
I.6.1 Induction of apoptosis with Actinomycin D and Puromycin 
 
In this work apoptosis was induced by treating cells with 1 µM Actinomycin D or 
50 µM Puromycin for different time points. These inducers were decided due to the 
well known mode of action. 
 
 
Actinomycin D is an antibiotic which forms a complex 
with dsDNA. Subsequently DNA-primed RNA 
synthesis is inhibited. Actinomycin D can also lead to 
DNA single-strand breaks (Sigma-Aldrich). 
Fig. 8: Structure of Actinomycin 
D (Sigma-Aldrich) 
 
 
Puromycin is an antiobiotic of the 
aminonucleoside family. It is isolated from 
Streptomyces alboniger. Puromycin inhibits 
protein synthesis by mimicking the 3´end of 
an aminoacyl-tRNA, subsequently leading to 
premature chain termination. (Sigma-Aldrich) 
Fig. 9: Structure of Puromycin (Sigma-
Aldrich) 
 
 
I.6.2 Induction of apoptosis in a cell-free system 
 
In 1996 a cell-free system was reported where apoptosis could be induced by the 
addition of dATP and cytochrome c (Liu, Kim et al. 1996). The authors used cytosolic 
extracts from HeLa S3 cells and isolated nuclei. This system showed characteristic 
apoptotic properties as observed in cells like caspase-3 activity and DNA 
fragmentation. These in vitro studies enabled them to identify cytochrome c as an 
important factor in apoptosis. 
The advantage of a cell-free system is the possibility to study events downstream of 
mitochondria in the apoptotic pathway regardless of pre-mitochondrial events. 
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I.7 The MCF-7 cell line as model system for apoptosis 
 
The MCF-7 cell line is a human breast cancer cell line and derived from a patient in 
1970. MCF-7 cells are widely used as model system for apoptosis and 
chemoresistance (Simstein, Burow et al. 2003). There are distinct lineages of this cell 
line with different properties in regard of apoptosis. MCF-7 cells are relatively 
insensitive to apoptotic inducers. It was concluded that MCF-7 variants reflect the 
apoptotic-resistant phenotypes of breast cancer in vivo (Simstein, Burow et al. 2003). 
Important to mention is that the MCF-7 cell line does not express caspase-3. This is 
because of a deletion in the casp-3 gene. But it was demonstrated that MCF-7 cells 
are able to activate other caspases. It is described that apoptosis can occur in MCF-7 
cells by sequential activation of caspase-9, -7 and -6. Further it was shown that 
caspase-3 is not required for TNF-induced apoptosis. Characteristic features of 
apoptosis, like morphological changes or DNA fragmentation are not always 
observed in MCF-7 cells. If caspase-3 is restored, cells are more sensitive to 
apoptosis induction by etoposide (Simstein, Burow et al. 2003). 
MCF-7 cells are used as model for chemoresistance. It was shown that long time 
exposure to TNF result in resistance to this drug. Interestingly, chemoresistance 
seems to be determined by the PI3K/Akt pathway (Simstein, Burow et al. 2003). 
 
 
I.8 Assays to determine cell death 
 
Several different techniques to analyse cell death exist. Here selected methods which 
are commonly used are discussed: 
 
I.8.1 Exclusion of dyes 
 
This method is based on the exclusion of vital dyes from cells due to plasma 
membrane integrity. Such dyes are membrane-impermeable and can only enter the 
cell when the plasma membrane is disrupted. (Fink and Cookson 2005; Galluzzi, 
Maiuri et al. 2007) 
Examples are propidium iodide (PI) and trypan blue. PI is often used in flow 
cytometry whereas trypan blue is used in microscopy. 
This method does not imply the mechanism of cell death because membrane 
destruction is a unique feature of dying cells. (Fink and Cookson 2005; Galluzzi, 
Maiuri et al. 2007) 
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I.8.2 Annexin V staining 
 
Phosphatidylserine (PS) is usually located on the inner leaflet of the plasma 
membrane. The externalization of PS is a recognition signal for phagocytosis and 
takes place early during apoptosis when the plasma membrane is still intact. PS 
exposure can be detected by labelled Annexin V which binds specifically to this 
phospholipid. This interaction can be measured subsequently by flow cytometry (Fink 
and Cookson 2005; Galluzzi, Maiuri et al. 2007). It is reported that externalization of 
PS was also observed in oncotic cells (Fink and Cookson 2005). Further it has been 
shown that PS exposure also occur in T-cell activation without cell death (Galluzzi, 
Maiuri et al. 2007). 
 
 
I.8.3 Immunoblotting 
 
The activity of caspases can be determined by western blotting. These proteases are 
described in detail in section I.4.3 and cleave a lot of cellular substrates when active. 
Antibodies against such substrates can be used to detect caspase activity.  
 
 
I.8.4 Terminal deoxynucleotidyl transferase-mediated dUTP nick 
end labeling (TUNEL) assay 
 
The TUNEL staining is based on the activity of the terminal deoxynucleotidyl 
transferase which is used to label 3´ends of DNA breaks with biotinylated 
nucleotides. DNA fragmentation can occur during cell death but it is not exclusively 
seen in apoptosis (Galluzzi, Maiuri et al. 2007). The TUNEL staining is evaluated by 
microscopy. Detection of DNA laddering is one frequent used technique to analyse 
cell death. It can also be analysed by gel electrophoresis (Fink and Cookson 2005). 
 
 
I.8.5 Cell based assays 
 
A lot of different assays are available to measure viability or caspase activity of cells. 
In this study among other things a proliferation assay and a caspase assay 
purchased from Promega was used. Details can be found in the section materials 
and methods. 
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I.9 The PI3K/Akt pathway 
 
Akt (also called protein kinase B, PKB) is a serine/threonin kinase. This kinase is 
activated in response to extracellular growth factors and survival stimuli. The Akt 
pathway is now thought to play an important role in signal transduction. It controls cell 
proliferation and survival (Song, Ouyang et al. 2005). 
Three isoforms of Akt exist. All of them have a conserved structure. This includes an 
amino-terminal pleckstrin homolgy (PH) domain which enables binding to 3-
phosphoinositides. Further Akt has a central kinase domain as well as a carboxy-
terminal regulatory domain. Akt contains two phosphorylation sites Thr308 and 
Ser473. For full enzymatic activity phosphorylation of both sites is required. Akt is 
partially active if Thr308 is phosphorylated alone. But phosphorylation of Ser473 
alone has only a little effect on its activity (Song, Ouyang et al. 2005). 
 
 
I.9.1 Activation of Akt 
 
Phosphoinisitide 3-kinase (PI3K) is activated by tyrosine kinase or G-protein coupled 
receptors. Subsequently PI3K phosphorylates phosphoinistol (4,5)-diphosphate 
(PIP2) generating phosphoinistol (3,4,5)-triphosphate (PIP3) which serves as second 
messenger (Fig. 10). This enables the recruitment of Akt to the plasma membrane. 
Akt binds PIP3 due to the PH domain. This alters the conformation of Akt and is a 
prerequisite for its activation. Akt consists of two phosphorylation sites. Thr308 is 
phosphorylated by phosphoinositide-dependent kinase-1 (PDK1) after Akt is recruited 
to the plasma membrane. The phosphorylation of Ser473 is required for full activation 
of Akt. However, this phosphorylation step is not understood completely. It was 
assumed that PDK1 also phosphorylates Ser473. But there is evidence that PDK1 
contributes to this phosphorylation only in an indirect manner. It was reported further 
that Akt could autophosphorylate itself at this residue under certain conditions (Song, 
Ouyang et al. 2005). 
 
Akt can be also activated in a PI3K independent manner. In this case Akt can be 
activated by PKA (protein kinsase A). For this kind of activation the PH domain of 
Akt1 is not necessary. The mechanism how Akt is activated in a PI3K independent 
manner is not clear (Song, Ouyang et al. 2005). 
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Fig. 10: PI3K signaling. One way in which PI3K promotes cell survival. (PKB=Akt) 
(Alberts, Johnson et al. 2002) 
 
 
 
I.9.2 Consequences of activation of Akt 
 
In general active Akt, which is a serine/threonin kinase provides a strong survival 
signal for the cell. Further Akt influences the apoptotic pathway directly by acting on 
the pro-apoptotic BAD protein, which is a member of the Bcl-2 family. 
Human caspase-9 is also phosphorylated by Akt directly. This phosphorylation leads 
to an attenuation of the activity of caspase-9. This regulatory step is not conserved in 
lower mammalian species. 
The Akt pathway also controls cell survival on the level of transcription. The family of 
Forkhead (FoxO) transcription factors are phosphorylated directly by Akt. The target 
genes of FoxO transcription factors include the gene of FasL as well as genes of 
intracellular components for apoptosis. Pro-survival genes are also expressed due to 
activation of nuclear factor-κB (NFκB) by Akt. These genes include Bcl-XL and 
caspase inhibitors. 
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I.10 Pyrrolidine dithiocarbamate (PDTC) 
 
Pyrrolidine dithiocarbamate (PDTC) is a metal chelating compound and is studied for 
many years. Quite a lot of properties of this substance are described in the literature. 
The reported effects are controversial and depend on the model system used. This 
section summarizes current knowledge about PDTC. 
 
PDTC is a copper and zinc ionophore with anti-oxidant 
properties. It is a thiol (R-SH) and thus PDTC can react 
with sulfhydrylgroups. PDTC is a white solid compound 
and stable when dissolved in water. Fig. 11 shows the 
structure of PDTC. 
 
 
 Fig. 11: Structure of PDTC 
 
 
 
I.10.1 Reported effects of PDTC on apoptosis 
 
PDTC was described as a pro-apoptotic substance by Erl et al. (Erl, Weber et al. 
2000). In this study it was shown that PDTC can induce apoptosis in different primary 
cells such as human umblical vein endothelial cells (HUVEC) and human fibroblasts. 
It was found out that not only the cell type but also the cell density are crucial for 
induction of apoptosis. The authors demonstrated further that the presence of Cu2+ 
and Zn2+ are required for PDTC activity (Erl, Weber et al. 2000). 
Another study demonstrates pro-apoptotic properties of PDTC at low concentrations 
(Della Ragione, Cucciolla et al. 2000). Herein the promyelocitic cell line HL-60 was 
used. It is shown that PDTC cause cytochrome c release after five hours. Additional 
isolated mitochondria were incubated with PDTC and release of cytochrome c was 
observed in vitro. Thus it was concluded that the mitochondria are the main target of 
PDTC (Della Ragione, Cucciolla et al. 2000). 
 
Controversial to the previous cited study Cheng et al. demonstrated anti-apoptotic 
effects of PDTC in HL-60 cells (Cheng, Huang et al. 2006). In this study apoptosis 
was induced by luteolin. It was found out that PDTC decreases apoptosis in a dose 
dependent manner but it was unable to prevent luteolin-induced cytochrome c 
release. It was also demonstrated that Akt was phosphorylated in the presence of 
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luteolin and PDTC. But PDTC alone failed to cause the phosphorylation of Akt. The 
authors concluded that the inhibitory effects of PDTC might be due to activation of 
Akt and subsequently phosphorylation of caspase-9 (Cheng, Huang et al. 2006). 
Another study reporting inhibitory effects of PDTC on apoptosis was published in 
1997 by Nobel et al. (Nobel, Burgess et al. 1997). Herein the general mechanisms of 
ditihiocarbamates to inhibit apoptosis were analysed. The behaviour of these 
substances was investigated in etoposide-induced apoptosis in thymocytes. It was 
found out that dithiocarbamates are more potent to inhibit apoptosis in thymocytes 
when they are oxidized to their respective disulfides. This oxidation step is achieved 
in cell culture experiments by Cu2+ in the serum. The authors report an inhibitory 
effect of dithiocarbamates on the activation of caspase-3 in a cell-free system. 
Interestingly PDTC showed no such activity. However, it is proposed that 
dithiocarbamate disulfides themselves are anti-apoptotic by interaction with 
caspases. But they loose their inhibitory activity when they are metabolized (Nobel, 
Burgess et al. 1997). 
 
 
I.10.2 Other effects of PDTC 
 
Also other effects of PDTC are reported. One study reported that PDTC and zinc can 
inhibit proteasome-dependent proteolysis (Kim, Kim et al. 2004). It was found out that 
treatment of HeLa cells with PDTC resulted in the accumulation of several 
proteasome substrates. It is also shown that zinc and copper ions can influence 
ubiquitin-proteasome activity (Kim, Kim et al. 2004). 
PDTC is used as an inhibitor of nuclear factor-κB (NF-κB). One paper reporting this 
fact is published by Kim et al. (Kim, Kim et al. 1999). In this study PDTC was not able 
to inhibit NF-κB in the absence of serum. Interestingly zinc and copper restored its 
inhibitory activity. A low zinc concentration was sufficient to observe this effect. The 
authors concluded that the interaction of PDTC with zinc is the likely mechanism of 
influencing NF-κB activity (Kim, Kim et al. 1999). 
Further PDTC exhibits antiviral properties. It was shown that PDTC is able to inhibit 
the processing of viral polyprotein of picornaviruses (Krenn, Holzer et al. 2005; 
Lanke, Krenn et al. 2007). The authors demonstrated that PDTC interferes with viral 
RNA synthesis thus inhibiting viral replication. These properties of PDTC are 
mediated by the import of zinc ions into cells (Lanke, Krenn et al. 2007). 
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Effects of PDTC were also observed in vivo. It is reported that PDTC improves 
cognitive function in a transgenic animal model of Alzheimer´s disease (Malm, 
Iivonen et al. 2007). In this study less phosphorylation of the tau protein was found 
due to PDTC treatment. Further it was observed that PDTC increases Akt 
phosphorylation as well as copper concentration in the brain. Therefore it was 
hypothesized that PDTC provides this beneficial effect in the animal model due to 
copper-mediated activation of Akt (Malm, Iivonen et al. 2007). 
 
 
I.11 Cellular processes affected by zinc 
 
Zinc is a ubiquitous trace element which is important as structural constituent of 
many proteins and enzymes. In multicellular organisms 40 % of intracellular zinc is 
located in the nucleus and 50 % in the cytosol. Zinc is required for the biological 
function of 300 enzymes. The deprivation of this trace element for example by 
chelation leads to cell death (Stefanidou, Maravelias et al. 2006). 
 
 
I.11.1 The PI3K/Akt pathway can be stimulated by zinc 
 
Zinc is known to cause insulin-like effects in various cell types. This includes the 
activation of the PI3K/Akt pathway. It was shown that the activity of PI3K can be 
increased in response to zinc exposure. A primary cellular target of zinc upstream of 
PI3K was not found (Barthel, Ostrakhovitch et al. 2007). 
Only certain ions are able to activate the PI3K/Akt pathway. These ions are Zn2+, 
Cu2+ and Cd2+. All of them show similarities regarding activation of Akt. Zinc, copper 
and cadmium are known as thiol-reactive ions and they cause phosphorylation of Akt 
in a PI3K dependent manner. This was concluded due to the fact that this 
phosphorylation can be abolished by the presence of PI3K-inhibitors such as 
wortmannin (Barthel, Ostrakhovitch et al. 2007). 
Protein tyrosine phosphatases (PTPases) are targets of such thiol-reactive 
compounds. One of them is PTEN which dephosphorylates PIP3. In airway epithelial 
cells it was shown that PTEN protein levels are lost due to Zn2+ treatment 
subsequnetly leading to activation of Akt. By contrast zinc was shown to stimulate 
cell death via Akt signaling in neurons. This means that the outcome of zinc 
treatment depends on the cell type (Barthel, Ostrakhovitch et al. 2007). 
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I.11.2 Zinc as regulator of apoptosis 
 
Zinc is a biometal and shows cytoprotective effects (Truong-Tran, Carter et al. 2001). 
If cells are supplemented with zinc in vitro as well as in vivo the susceptibility to 
undergo toxin-induced apoptosis decreases. For this effect the labile intracellular 
zinc-pools are important. It is reported that a deprivation of zinc in vivo leads to an 
increase of apoptosis (Truong-Tran, Carter et al. 2001). Also in vitro studies revealed 
that apoptosis is induced by treatment of cells with zinc-depleted medium or TPEN, a 
zinc chelator. This zinc deficiency- induced apoptosis depends on caspase-3 activity. 
Further it was shown that zinc was able to block apoptosis by all apoptosis-inducing 
treatments tested. This finding leads to the idea that zinc suppresses a common 
event (Truong-Tran, Carter et al. 2001). 
In vivo studies support the idea that intracellular zinc levels can be changed easily 
and thus protect cells and tissues from apoptosis. But two major problems arose from 
in vitro studies. These studies were often done with supraphysiological zinc 
concentrations. The reason for this is the poor uptake of zinc into cells. But the 
problem is that high concentrations of intracellular zinc can cross-link proteins non-
specifically (Truong-Tran, Carter et al. 2001). The second difficulty is the possibility 
that zinc depletion and supplementation studies measured different effects of zinc. 
This might be the case if zinc has more than one target in the cell. However, 
cytoprotective agents seems to act at pre-mitochondrial or mitochondrial stages, 
rather than on the level of caspases (Truong-Tran, Carter et al. 2001). 
As cytosolic target of zinc, caspase-3 was identified (Truong-Tran, Carter et al. 
2001). This finding is controversal because other studies disagree and find caspase-
3 relatively zinc-insensitive (Truong-Tran, Carter et al. 2001). Interestingly, in airway 
epithelial cells zinc was found to be co-localized with procaspase-3. There is 
evidence that zinc blocks the activation of caspase-3 rather than the enzyme itself. 
However, in cell-free systems it was shown that the presence of zinc inhibits PARP-
cleavage by caspase-3 (Truong-Tran, Carter et al. 2001).  
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This and other studies lead to the conclusion that zinc may interact with a sulfhydryl 
group in caspase-3 (Fig. 12) (Truong-Tran, Carter et al. 2001). 
 
 
 
 
 
Fig. 12: Model of caspase-3 inhibition by zinc. It is proposed that zinc binds to Cys163 in the 
active centre and inhibiting this enzyme reversibly. DEVD-AFC represents a fluorogenic substrate 
which is cleaved due to caspase-3 activity. 
(Truong-Tran, Carter et al. 2001) 
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Aim 
 
 
 
Pyrrolidine Dithiocarbamate (PDTC) is a substance which exhibits quite a lot of 
different effects in biological systems. PDTC is described as inducer as well as 
inhibitor of apoptosis (Nobel, Burgess et al. 1997; Della Ragione, Cucciolla et al. 
2000; Erl, Weber et al. 2000; Cheng, Huang et al. 2006). This property depends on 
the model system used. In our laboratory pre-exisiting data suggests an anti-
apoptotic effect of PDTC. 
Further it is described that PDTC is able to inhibit cellular processes like proteasome-
dependent proteolysis, the activation of NFκB as well as the replication of 
picornaviruses (Krenn, Holzer et al. 2005; Lanke, Krenn et al. 2007). In all these 
cases the presence of certain metal ions (i.e. zinc, copper) is a prerequisite for the 
function of PDTC. It was also shown that PDTC increases the concentration of 
intracellular zinc (Lanke, Krenn et al. 2007). 
 
The aim of this project was to find out how PDTC is able to inhibit apoptosis and 
which steps of the apoptotic pathway are affected. 
It was assumed that the increase of intracellular [Zn]2+ by PDTC is important in 
preventing apoptosis. Zinc is known to inhibit caspase-3 and to activate the PI3K/Akt 
pathway, which provides survival signals for the cell (Truong-Tran, Carter et al. 2001; 
Barthel, Ostrakhovitch et al. 2007). 
To analyse the anti-apoptotic effect of PDTC HeLa cells, caspase-3 deficient MCF-7 
and caspase-3 overexpressing MCF-7cas3+ cells were used. Apoptosis was induced 
in these cell lines with Actinomycin D or Puromycin. These two substances were 
used to induce cell death due to the well known mode of action. 
First, to determine the impact of PDTC on apoptosis in the model system used 
viability- and/or caspase-3/7 assays were done. The influence of PDTC on the 
release of cytochrome c from mitochondria was analysed by subcellular fractionation. 
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Second, to analyse the effect of PDTC on caspase-9 processing and subsequently 
on caspase-3 a cell-free system composed of cytosolic extracts and nuclei of 
HeLa S3 cells was used. Apoptosis was induced in this system by addition of 
cytochrome c and (d)ATP. Effects of PDTC on caspase-3 were also analysed in 
caspase-3 overexpressing MCF-7-cas3+ cells as well as in caspase-3 deficient MCF-
7 cells by using flow cytometry. 
Third, the ability of PDTC to activate the PI3K/Akt pathway, which provides a survival 
signal for cells (Alberts, Johnson et al. 2002), was determined by western blotting. 
Further it was checked if the inhibition of this pathway by wortmannin could abolish 
the anti-apoptotic effect of PDTC. 
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Materials and Methods 
 
 
III.1 Tissue Culture 
 
 
III.1.1 Cell lines 
 
Cell line Description Culture Conditions Source 
HeLa cervix carcinoma 
cells 
RPMI 1640, 
10 % Fetal calf serum, 
2 mM L-Glutamine, 
100 U/ml Penicillin, 
100µg/ml Streptomycin
ATCC CCL-2 
HeLa S3 cervix carcinoma 
cells 
DMEM, 
10 % Fetal calf serum, 
2 mM L-Glutamine, 
100 U/ml Penicillin, 
100µg/ml Streptomycin
ATCC CCL-2.2 
MCF-7 breast cancer cells RPMI 1640, 
10 % Fetal calf serum, 
2 mM L-Glutamine, 
100 U/ml Penicillin, 
100µg/ml Streptomycin
Rainer, 
Jäniche, 
Düsseldorf 
MCF-7-Cas3+ breast cancer cells 
overexpressing 
caspase-3 
RPMI 1640; 
10 % Fetal calf serum, 
2 mM L-Glutamine, 
100 U/ml Penicillin, 
100µg/ml Streptomycin
Rainer, 
Jäniche, 
Düsseldorf 
 
 
III.1.2 Media and Chemicals 
 
? RPMI growth medium 
RPMI 1640 -L-Glutamine, Gibco 
 10 % heat inactivated FCS 
 1 % L-Glutamine stock solution 
1 % Penicillin-Streptomycin 
stock solution 
 
? DMEM growth medium 
 DMEM, Gibco 
 10 % heat inactivated FCS 
1 % Penicillin-Streptomycin 
stock solution 
 
? 1x Trypsin-EDTA, PAA 
 
? Fetal calf serum (FCS), Gibco 
heat inactivation by incubation 
at 56°C for 30 min 
 
? 100x L-Glutamine, Gibco 
200 mM stock solution 
 
 
? Penicillin-Streptomycin, 
stock solution, Gibco 
10.000 U/ml Penicillin, 
10.000 µg/ml Streptomycin 
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? 10x PBS 
 11,5 g Na2HPO4*2H2O 
 80 g NaCl 
 2 g KCl 
 2 g KH2PO4 
 ad 1l dH2O; pH 7,4 
 
? Dimethylsulfoxid (DMSO), 
Sigma Aldrich 
 
? Pyrrolidine Dithiocarbamate (PDTC), 
ALEXIS Biochemicals 
500 mM stock solution in dH2O, 
stored at -20°C; 
10 mM working solution is 
prepared by dilution 1:50 in PBS 
 
 
 
? Actinomycin D, Sigma Aldrich 
1 mM; dissolved in DMSO; 
stored at -20°C 
 
? Puromycin Dihydrochloride, 
Sigma Aldrich 
10 mM; dissolved in dH2O; 
stored at -20°C 
 
? Wortmannin, Sigma Aldrich 
2,3 mM; dissolved in DMSO; 
stored at -20°C 
 
? EDTA, 50 mM, sterile 
 
 
 
 
 
 
III.1.3 Cell culture 
 
Cells are grown in tissue culture flasks (Nunc) at 37°C, 5 % CO2 in humidified 
atmosphere. To split cells, the medium is discarded and the monolayer is rinsed with 
1xPBS. One ml Trypsin-EDTA is added to a 75 cm2 flask. The cells are incubated for 
5-10 min until the cells detach from the surface. 10 ml fresh growth medium are 
added to neutralize the Trypsin and a homogenous cell suspension is created by 
pipetting up/down. In the case of HeLa cells, the suspension is ready to use for 
passaging into a new flask/dish. All other cells are centrifuged after trypsinisation to 
remove the trypsin completely. After resuspending in fresh growth medium the cells 
are transferred into desired flasks/dishes. 
 
Area [cm2] Trypsin [ml] Medium [ml] 
75 1 12 
225 2-2,5 30 
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III.1.4 Counting of cells 
 
Cells are counted by using a hemato-cytometer (Neubauer improved). Therefore a 
50 µl aliquot of the desired cell suspension is taken and diluted 1:5 or 1:10 with 
medium. Cells are counted in all four chambers of the hemato-cytometer and the 
average is calculated. Cell concentration is determined according to the following 
equation: 
 
[Average] x [Dilution] x 104 = cells/ml 
 
 
III.1.5 Freezing/Thawing of cells 
 
A Cryo-freezing container (Nalgene) is pre-cooled at 4°C. Cells are harvested by 
trypsinisation. Desired cell number (1*106-3*106 cells) in a total volume of 900 µl is 
transferred into a cryo-tube (Nunc) and 100 µl DMSO added. The cryo-tube is 
inverted immediately several times and placed into the pre-cooled freezing chamber. 
Afterwards the freezing-chamber is put at -80°C for at least 24 h. Finally the cryo-
tube is transferred into liquid nitrogen. 
To thaw cells the desired cryo-tube is immediately thawed at 37°C in the water bath. 
The cell suspension is transferred into a 50 ml Falcon where the cells are rinsed 
slowly with 10 ml growth medium. The cells are centrifuged (300 g, 4 min) and the 
residual supernatant is removed. Finally the cells are resuspended in the desired 
volume and seeded into a culture-flask. On the next day the medium is changed to 
remove the last traces of DMSO. 
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III.2 Protein detection methods 
 
 
III.2.1 Subcellular fractionation 
 
 
Material: 
 
? SEM buffer 
 250 mM  Sucrose 
10 mM  4-Morpholine-
propanesulfonic 
acid (MOPS) 
1 mM  Ethylenediamine- 
tetraacedic acid 
(EDTA) 
 100 mM  KCl 
 1,5 mM  MgCl2 
1 mM  Ethylen-glycol-
bis(2-
aminoethylether)-
N,N,N´,N´-
tetraacetic acid 
(EGTA) 
 pH 7,2; KOH 
 
 
? 25x Protease Inhibitor Cocktail 
Dissolve one tablette of EDTA-
free Complete Protease Inhibitor 
(Roche) in 2 ml dH2O. Aliquot 
and store at -20°C. 
 
? 1xPBS 
 
? Douncer, 7 ml, Wheaton 
 
 
 
 
 
 
 
 
 
Method: 
 
To analyse the release of cytochrome c from mitochondria into the cytosol which is a 
hallmark of apoptosis, subcellular fractionation was done. This method results in 
three different fractions designated as “total cell extract”, “Mitochondria” and 
“Cytosol”. 
5*106 cells are seed on one 15cm dish and incubated for two days at 37°C in 
humidified atmosphere. Medium is removed and cells are treated with desired drug. 
After different time points the supernatant which contains floating cells is transferred 
to a 50 ml Falcon tube. Attached cells on the dish are washed with cold 1xPBS. After 
PBS is removed completely 0,75 ml SEM buffer containing protease inhibitors is 
added to each dish. Cells are harvested by using a cell scraper and transferred to a 
Eppendorf tube. 
The floating cells in the Falcon tube are centrifuged (300 g, 4°C, 4 min), supernatant 
is removed by decantation. To wash cells, approximately 10 ml of ice cold 1xPBS are 
added. The cell pellet is carefully resuspended by shaking the tube slightly and 
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centrifuged again (300 g, 4°C, 4 min). Afterwards PBS is removed completely. To 
merge the cell pellet with the already harvested cells, a small amount of the cell-
suspension in the Eppendorf tube is added to the cell pellet. Cells are resuspended 
by pipetting and transferred to the Eppendorf tube again. This is necessary to 
minimize the volume. 
Finally cells are transferred to a pre-cooled 7 ml Douncer (Wheaton) on ice. Cells are 
disrupted with 100 strokes using a type B pestill. Successful disruption is checked by 
trypan blue staining. An aliquot of 50 µl is taken and designated as “total cell extract” 
containing nuclei. Disrupted cells are transferred into an Eppendorf tube and 
centrifuged in a micro-centrifuge (600 g, 4°C, 5 min). The supernatant is transferred 
to a new tube. 
The pellet is resuspended in 100 µl SEM buffer containing protease inhibitors 
followed by centrifugation (600 g, 4°C, 5 min). This step is necessary to increase the 
yield of mitochondria. Both supernatants are merged and centrifuged (13600 g, 4°C, 
15 min). 100 µl of the supernatant are taken and designated as “cytosolic fraction”. 
The mitochondrial pellet is washed with 100 µl SEM buffer containing protease 
inhibitors and centrifuged (13600 g, 4°C, 15 min). Finally the mitochondrial pellet is 
resuspended in 50 µl SEM buffer containing protease inhibitors. All fractions are 
stored at -20°C until further analysis. 
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III.2.2 Cell-free System for apoptosis 
 
 
Material: 
 
? Buffer N (hypotonic) 
10 mM Hepes 
2 mM MgCl2 
25 mM KCl 
pH 7,5; KOH 
 
? Buffer N+ 
10 mM Hepes 
2 mM MgCl2 
25 mM KCl 
250 mM Sucrose 
pH 7,5; KOH 
 
? Buffer A 
20 mM Hepes 
10 mM KCl 
1,5 mM MgCl2 
1 mM EDTA 
1 mM EGTA 
pH 7,4; KOH 
 
? Aprotinin, 1 mg/ml 
 
? Pepstatin, 1 mg/ml 
 
? Leupeptin, 10 mg/ml 
 
? 100 mM Phenylmethylsulfonyl- 
fluoride (PMSF) stock solution in 
methanol 
 
? 214 mM Dithiothreitol (DTT) 
 
? 40 mM ATP 
 
? 100 mM dATP 
 
? 800 µM Cytochrome c, 
from bovine heart, >95%, 
Sigma Aldrich 
dissolved in PBS and stored at  
-20°C 
 
? 0,4 % w/v Trypan blue 
 
? 2 M Sucrose 
 
 
 
 
Method: 
 
To analyse the influence of PDTC on the apoptotic events downstream of 
cytochrome c release a cell-free system was used similar to those published (Liu, 
Kim et al. 1996). 
7,5*106 HeLa S3 are seeded on 15 cm dishes and incubated for two days at 37°C in 
humidified atmosphere. The supernatant is discarded and the cells are immediately 
washed with ice-cold PBS. All further steps are carried out on ice. PBS is removed 
completely and 0,75 ml Buffer A supplemented with Pepstatin (1:1000), Leupeptin 
(1:1000), Aprotinin (1:1000), PMSF (1:1000) and DTT (1:214) are added. Cells are 
harvested by using a cell-scraper, transferred into an Eppendorf tube, incubated 
20 min on ice and finally pushed through a 26G needle. The success of the 
disruption is checked by trypan blue staining. Usually approximately 40 strokes are 
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required to reach 90 % blue cells. The homogenate is centrifuged in a micro-
centrifuge (13.600 g, 15 min, 4°C) and the supernatant transferred into a pre-cooled 
1,5 ml Beckman-ultra-centrifuge tube and the nuclear-pellet is kept on ice. Now the 
supernatant is re-centrifuged using a Beckman ultra-centrifuge (Optima TLX 
Ultracentrifuge, rotor TLA 100.3, 100.000 g, 1 h, 4°C). The resulting supernatant is 
designated as S100 cytosolic-fraction. 
The nuclear pellet is resuspended by pipetting in 1 ml Buffer N (hypotonic) 
supplemented with protease-inhibitors as described above, 125 µl 2 M sucrose are 
added and mixed well by inversion. The nuclei are centrifuged (300 g, 4 min, 4 °C) 
using a swinging-bucket rotor (Heraeus Sepatech #2704). 
The supernatant is discarded and the pellet is resuspended in 1 ml BufferN+ 
supplemented with protease-inhibitors as described followed by a second 
centrifugation (300 g, 4 min, 4°C, swinging-bucket rotor Heraeus Sepatech #2704). 
The supernatant is removed and the nuclei are resuspended in 100 µl Buffer N+ 
containing the same protease inhibitors as described above. 
Nuclei and cytosolic fraction are mixed in a ratio 1:10. To induce apoptosis 
1 mM dATP, 1 mM ATP and 10 µM cytochrome c are added. As negative control one 
reaction is prepared without the addition of cytochrome c. Reactions are incubated at 
37°C, 600 rpm and aliquots of each are taken after desired time points. Immediately 
4x sample buffer is added to the aliquots and heated for approximately 30 min at 
95°C to stop the reaction. Samples are stored at -20°C and are analysed by western 
blotting.  
 
 
III.2.3 Preparation of cell extracts 
 
Material: 
 
? 5x Sample buffer 
 10 ml  Glycerol 
 5 ml  ß-Mercaptoethanol 
 3 g  SDS 
3,8 g  Tris-(hydroxymethyl)-
aminomethane (Tris) 
 3 mg  Bromphenolblue 
 pH 6,8; HCl 
 
? 1x sample buffer 
dilute 5x sample buffer 1:5 with 
dH2O 
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Method: 
 
Cells are seeded in 12 well plates and treated as desired. To collect floating cells, the 
medium is transferred into an Eppendorf-tube and centrifuged (15.800 g, 3 min, RT). 
The supernatant is discarded. Attached cells are lysed by adding 50 µl 1x sample 
buffer. Proteins are harvested by scraping with the pipette-tip and added to the cell-
pellet. Samples are heated at 95°C for approximately 30 min prior western blot 
analysis. 
 
 
III.2.4 Tris/Tricine PAGE 
 
Material: 
 
? Acryl-/Bisacrylamide stock solution 
 300 g  Acrylamide 
 8 g  Methylenbisacrylamide 
Dissolve in 1l dH2O. Filter and 
store at 4°C. 
 
? Anode buffer 
 0,2 M  Tris 
 pH 8,9; HCl 
 
? APS 
10 % w/v 
Ammoniumperoxodisulfat in 
dH2O 
 
? Cathode buffer 
 0,1 M   Tris 
 0,1 M   Tricine 
 0,1 % w/v 
 Sodiumdodecylsulfate (SDS) 
 no pH 
 
? 87% v/v Glycerol 
 
? 5x Sample buffer 
 10 ml  Glycerol 
 5 ml  ß-Mercaptoethanol 
 3 g  SDS 
 3,8 g  Tris 
 3 mg  Bromphenolblue 
 pH 6,8; HCl 
 
? Stack Solution 
 12,5 ml 4xUGS 
 6,5 ml 30% Acrylamide 
 31 ml dH2O 
 
? TEMED 
N,N,N´,N´-
Tetramethylethylethylene-
diamine 
 
? 3x Tris/HCl SDS buffer 
 1,5 M   Tris 
 0,15 % w/v SDS 
 pH 8,45; HCl 
 
? 4x UGS (upper gel solution) 
 0,5 M   Tris 
 0,4 % w/v  SDS 
 pH 6,8; HCl 
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Method: 
 
Tris/Tricine PAGE is used for good separation of small proteins. Gel apparatus is 
assembled according to the manufacturer’s instructions. For preparing one 
seperating gel the following solutions are mixed. 
 
 
 
 1 x 
Acrylamide 30 % 2 ml 
3x Tris/HCl/SDS pH 8,45 2 ml 
dH2O 1,4 ml 
Glycerol 0,6 ml 
APS 36 µl 
TEMED 3,6 µl 
 
After the solution is filled into the gel apparatus 1 ml of dH2O is added carefully to 
ensure a smooth surface. After 30 min the seperating gel is polymerised, the stack 
gel can be prepared. The water-layer of the seperating gel is removed prior adding 
the stack gel. 2 ml stack solution, 12 µl APS and 4 µl TEMED are mixed. Immediately 
afterwards the comb is put in the polymerising stack gel. 
After the stack gel is polymerised the comb is removed and the gel put into the 
electrophoresis unit. Cathode buffer is added to the upper chamber and anode buffer 
to the lower one. 
To prepare the samples an appropriate volume of sample buffer is added. Afterwards 
all samples are heated at 95°C for approximately 30 min, chilled on ice and 
centrifuged shortly. All samples are loaded at room temperature to avoid any 
precipitation of proteins. To run a gel a current of 20 mA/gel is applied. The loading 
dye reaches the end of the gel after approximately 1,5 h. Finally the gel is subjected 
to western blot analysis. 
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III.2.5 SDS PAGE 
 
Material: 
 
 
? Acryl-/Bisacrylamide stock solution 
 300 g  Acrylamide 
 8 g  Methylenbisacrylamide 
Dissolve in 1l dH2O. Filter and 
store at 4°C. 
 
? APS 
10 % w/v 
Ammoniumperoxodisulfat in 
dH2O 
 
? 4x LGS 
1,5 M Tris 
 0,4 % w/v SDS 
 pH 8,8; HCl 
 
 
 
? TEMED 
N,N,N´,N´-
Tetramethylethylethylene-
diamine 
 
? 10 x Running buffer 
 3,8 M Glycin 
 0,5 M Tris 
 1 % w/v SDS 
 
 
 
 
 
 
 
 
 
Method: 
 
A 7,5 % acrylamide gel is used to separate large proteins. In principle the method is 
the same as described above. For one separating gel the following solutions are 
mixed together: 
 
 1 x 
Acrylamide 30 % 1,5 ml 
4x LGS 1,5 ml 
dH2O 3 ml 
APS 36 µl 
TEMED 3,6 µl 
 
The rest of the procedure is the same as described for the Tricine PAGE except that 
there is only one running buffer. 
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III.2.6 Western Blot 
 
Material: 
 
? Anode Buffer 1 
 300 mM Tris 
 20 % v/v Methanol 
 
? Anode Buffer 2 
 25 mM Tris 
 20 % v/v Methanol 
 
? Albumin Bovine Serum (BSA), 
Fraction V, >96%, Sigma Aldrich 
 
? Cathode Buffer 
 40 mM 6-Amino-n-hexanoic acid 
 25 mM Tris 
 20 % v/v MeOH 
 
? ECL-Detection Kit, Pierce 
 
? Whatman Paper 
 
? PROTRAN(R), Nitrocellulose 
Transfer Membrane, 0,2 µm, 
Schleicher & Schuell 
 
 
 
? 1x PBS 
 
? PBST 
 1xPBS 
 0,1 % v/v Tween 20 
 
 
? Ponceau S, Sodium salt, 
Practical grade, Sigma Aldrich 
 0,1 % w/v in 1% v/v acetic acid 
 
? Non-fat dry milk 
 
? 10% w/v NaN3 
 
? Blocking solution 
5 % w/v non-fat dry milk in 
PBST 
 
 
 
 
 
 
 
 
 
Antibodies: 
 
Primary Antibodies: 
 
 Company Dilution used for Western Blot Source 
α Actin Sigma, A2066 1:8.000 Rabbit 
α pAkt(Ser473) Cell Signaling, 
4058S 
1:1.000 Rabbit 
α Akt Cell Signaling, 
9272 
1:1.000 Rabbit 
α Cleaved 
Caspase 9 
Cell Signaling, 
9501S 
1:500 Rabbit 
α COX IV abcam, ab14744 1:2.000 Mouse 
α Cyt c Invitrogen, 33-8500 1:500 Mouse 
α PARP Santa Cruz, 
sc7150 
1:2.500 Rabbit 
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Secondary Antibodies: 
 
 Company Dilution used for Western Blot 
α Mouse-HRP Jackson 1:40.000 
α Rabbit-HRP Jackson 1:20.000 
 
 
Method: 
 
Whatman paper is cut into 7 x 10 cm sheets. For one gel 10 sheets are required. A 
piece of nitrocellulose membrane with the dimensions 6 x 8 cm is cut out. To prepare 
a western blot the semy dry blotting machine is opened, three Whatman sheets are 
soaked with Anode buffer 1 and placed on the anode. Two sheets are soaked with 
Anode buffer 2 and placed above. The membrane is pre-rinsed with dH2O and put 
next. 
The gel is removed from the electrophoresis unit and one glass plate is removed. A 
dry sheet of Whatman paper is placed on the gel. Now the gel is carefully removed 
from the second glass plate and incubated in Cathode buffer. Air bubbles between 
gel and Whatman paper are removed. Finally the gel is put onto the nitrocellulose 
membrane. At the end four Cathode buffer-soaked sheets of Whatman paper are put 
on the sandwich. To ensure that no air bubbles can disturb the blotting process the 
surface of the sandwich is smoothed by using a Falcon tube. 
A constant voltage of 15 V is applied for at least one hour. The success of the 
blotting process is checked by Ponceau staining. Therefore the membrane is 
incubated in the Ponceau solution for approximately five min under slightly shaking. If 
necessary the membrane is cut in two pieces to probe with different antibodies 
simultaneously. The membrane is then de-stained with dH2O. To block unspecific 
binding sites the nitrocellulose membrane is put into a 50 ml Falcon tube and 
approximately 5 ml blocking solution are added. The Falcon is put on a roller in the 
cold room (4°C) for one hour. Afterwards the blocking solution is discarded and the 
membrane is washed twice with PBST (5 min, 4°C, roller). The membrane is probed 
with the desired primary antibody. Therefore the antibody is diluted according to the 
table above in 4 ml PBST containing a small amount of BSA and 0,1 % w/v NaN3 to 
re-use the antibody. 
The membrane is incubated with the primary antibody over night at 4°C on a roller. 
Antibody dilutions can be stored at 4°C and re-used. Afterwards the blot is washed 
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three times with PBST. The secondary antibody is diluted in PBST and applied to the 
blot for two hours. Finally the blot is washed twice with PBST at room temperature 
under slightly shaking and washed once with PBS. 
For detection an equal amount of both ECL-solutions are mixed and applied to the 
blot immediately. Usually 1 ml of each solution was used for one blot. After an 
incubation period of five min at room temperature the membrane is placed into the 
film cassette and exposed to an x-ray film (CL-X Posure Film, Pierce). Exposure time 
ranges from 30 sec – 15 min. The film is developed by using an Agfa Curix60 
developing machine. 
 
 
III.2.7 Stripping of nitrocellulose-membranes 
 
Material: 
 
? 0,2 M NaOH 
 
 
 
 
? Blocking solution 
5 % w/v non-fat dry milk in 
PBST 
 
 
Method: 
 
The membrane is washed with dH2O for five min at room temperature under slightly 
shaking. 0,2 M NaOH is applied for five min. The blot is washed once with dH2O for 
five min. Finally the membrane is blocked for one hour at 4°C and washed twice with 
PBST. Now the blot can be re-probed with a new primary antibody. 
 
 
III.3 Flow Cytometry 
 
Material: 
 
 
? 438 µM Rhodamine 123 (R123) 
in Methanol 
 
 
 
? Propidiumiodide (PI), 
10 mg/ml in dH2O 
 
 
 
Method: 
 
The R123/PI staining allows discrimination between early- and late phase of 
apoptosis. Early apoptotic cells loose their mitochondrial membrane potential which 
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can be seen in R123 staining. Late apoptotic and necrotic cells loose their plasma 
membrane integrity thus PI can accumulate in these cells. 
1,5*106 cells are seeded on 60 mm dishes and incubated over night at 37°C. Cells 
are treated with desired drugs for certain time points. 
The supernatant is transferred into a 15 ml Falcon tube, the attached cells washed 
once with sterile 1xPBS and 0,5 ml trypsin is added per dish. Cells are incubated for 
approximately 5 min at 37°C until detachment. 
Four ml medium are added to each dish to neutralize the trypsin and the cell 
suspension is transferred into the 15 ml Falcon tube. Cells are centrifuged (300 g, 
4 min, RT) and resuspended in 3 ml medium. To one ml of cell suspension containing 
1*106 cells, 0,5 µl Rhodamine are added (200 nM final). Cells are incubated 20 min 
at 37°C in the dark. A control of un-stained cells is also required. Cells are 
centrifuged (300 g, 4 min, RT, swinging bucket rotor: Heraeus Sepatech #2704) and 
resuspended in one ml sterile PBS. One µl PI is added and cells are analysed by flow 
cytometry (BD LSR flow cytometer). Fluorescence is excited by a 488 nm laser and 
green (R123) and red fluorescence (PI) is collected. 
The instrument settings of the BD LSR are given in the following table: 
 
 
Detector Voltage AmpGain 
FSC-H --- 1 
SSC-H 680 4 
FL1-H 400 Log 
FL2-H 700 Log 
FL4-H 719 2 
FL5-H 500 4 
FL3-H 530 Log 
SSC-W 730 Log 
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III.4 Caspase 3/7 Assay 
 
Material: 
 
? Caspase-Glo(R) 3/7 Assay Kit, Promega, G8091 
 
 
Method: 
 
This assay is based on the cleavage of an artificial caspase substrate by active 
caspase 3/7 subsequently generating a substrate for luciferase. The emitted light is 
therfore proportional to the caspase 3/7 activity. 
1,5 *106 cells are seeded on one 96-well plate and incubated over night at 37°C. On 
the next day cells are treated with 50 µl/well 50 µM Puromycin, 1 µM Actinomycin D 
+/- 125 µM PDTC. For control desired wells are untreated or vehicle-treated (DMSO). 
The Caspase-Glo(R) 3/7 Reagent is prepared according to the manufacturers 
instructions. 
To start the assay the 96-well plate and the assay reagent are equilibrated to room 
temperature for a few minutes. 50 µl assay reagent are added to each well and 
mixed gently by shaking the plate. After incubation for 30 min at room temperature 
the reaction mixture is transferred into a 96-well white-walled plate. Finally the 
luminescence is read by a plate-reading luminometer (Berthold Technologies, Centro 
LB 960) for 10 s/well. 
 
 
III.5 Crystal Violet staining 
 
Material: 
 
? 0,2 % w/v crystal violet 
in 2 % v/v Ethanol 
 
? 1 % w/v SDS 
 
? 1xPBS 
 
 
 
 
Method: 
 
The principle of the assay is the retention of a dye by fixed cells on a plate. When the 
dye is solubilized the absorbance is proportional to the amount of attached cells. 
Cells are grown in a 96 well plate and treated as desired. Afterwards the medium is 
discarded and cells are washed twice with 100 µl/well 1xPBS. 50 µl/well crystal violet 
solution is added followed by incubation for 20 min at room temperature. The plate is 
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washed carefully with tap water to remove the excess of crystal violet and dried over 
night at room temperature. The dye is solubilized with 50 µl/well 1 % w/v SDS and by 
shaking the plate slightly. Absorbance is measured by a plate reader (Labsystems 
Multiskan RC) at 560 nm. 
 
 
III.6 Proliferation Assay 
 
Material: 
 
? CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay, G109C, Promega 
 
 
Method: 
 
This assay is based on the reduction of the tetrazolium salt MTS by dehydrogenase 
enzymes of viable cells. The generated formazan product is colored, soluble and can 
be measured at 490 nm. 
Cells are seeded in 96 well plates and treated as desired with a total volume of 
100 µl/well. MTS and PMS solution are thawed at room temperature or at 37°C. Two 
ml MTS solution and 100 µl PMS solution are mixed immediately before use. 20 µl of 
this solution are added to each well of the 96 well plate. Cells are incubated at 37°C 
for 1-4 h. Absorbance is read at 490 nm using a plate reader (Labsystems Multiskan 
RC). 
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Results 
 
 
 
IV.1 PDTC inhibits apoptosis in HeLa cells 
 
In the literature pro- as well as anti-apoptotic effects of PDTC are described (Nobel, 
Burgess et al. 1997; Della Ragione, Cucciolla et al. 2000; Erl, Weber et al. 2000; 
Cheng, Huang et al. 2006). Pre-existing data of our laboratory indicates an anti-
apoptotic effect of PDTC. To induce apoptosis HeLa cells were treated with 
Actinomycin D or Puromycin. The decision to use these inducers is based on their 
well known mode of action. Actinomycin D inhibits transcription whereas Puromycin 
inhibts translation (see introduction for details). HeLa cells were treated with 1 µM 
Actinomycin D or 50 µM Puromycin for different time points. These concentrations 
were decided, due to the appearance of cell death after 8-10 h. Cells were co-treated 
with or without 125 µM PDTC. This concentration of PDTC was not toxic for HeLa 
cells in the desired time frame. Subsequently different hallmarks of apoptosis were 
analysed. First of all the possibility of PDTC to counteract Actinomycin D or 
Puromycin-induced apoptosis was checked by microscopic observation, crystal violet 
staining, proliferation- and caspase 3/7 assay. 
 
Fig. 13 shows typical microscopic observations of HeLa cells treated with 
Actinomycin D with or without PDTC for different time points. DMSO was used as 
vehicle control. When apoptosis was induced with Actinomycin D no morphological 
intact cells are visible after 12 h. In contrast, if PDTC is present approximately fifty 
percent of the cells remain morphological intact after 12 h. 
 
 54
 
 
Fig. 13: HeLa cells were treated with 1 µM Actinomycin D +/- 125 µM PDTC for 4, 8 and 12 h 
respectively. More viable cells are observed when PDTC is present. 
 
 
Fig. 14 shows HeLa cells treated with 50 µM Puromycin +/- PDTC for 4, 8 and 12 
hours. The same situation as shown in Fig. 13 can be observed. When HeLa cells 
were treated with Puromycin alone, cell death appeared after 8 h. At this time point 
about 10 percent of Puromycin treated HeLa cells are morphologically intact. In 
contrast in the presence of PDTC, approximately 60 percent of the cells remain intact 
after 8 h. 
 
DMSO
4 h p.t. 
8 h p.t. 
12 h p.t. 
Act D Act D + PDTC
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Fig. 14: HeLa cells were treated with 50 µM Puromycin with or without PDTC for indicated time 
points. 
 
To quantify the observed protective effect of PDTC a crystal violet assay was done 
as described in material and methods. HeLa cells were treated with Actinomycin D or 
Puromycin +/- PDTC. After certain time points cells were stained with crystal violet. 
Finally the dye was solubilized and the absorbance measured. This assay is used to 
determine the amount of attached cells on the culture dish.  
 
Fig. 15 shows such an experiment. If apoptosis was induced by Actinomycin D or 
Puromycin, the amount of attached cells decreases in a time dependent manner 
(cyan and blue bars). This reflects the amount of apoptotic cells which are washed 
away during the staining procedure. PDTC, DMSO and untreated cells (mock) serve 
as controls. No significant differences between the controls can be seen indicating 
mock
4 h p.t. 
8 h p.t. 
12 h p.t. 
Puro Puro + PDTC
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that neither PDTC nor DMSO alone induce cell death in HeLa cells under the 
conditions used. If PDTC was present during induction of apoptosis this decrease 
was slower. This finding reflects the protective effect of PDTC (cyan- and blue-
striated bars). This experiment was done twice revealing similar results. 
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Fig. 15: Crystal violet staining of HeLa cells. Apoptosis was induced with 1 µM Actinomycin D or 
50 µM Puromycin +/- 125 µM PDTC. 
 
To measure the viability of HeLa cells after induction of apoptosis by Actinomycin D 
or Puromycin a proliferation assay was performed. This method was chosen because 
the activity of dehydrogenase enzymes in cells is a parameter for viability. Cells were 
treated with the inducer with or without PDTC for 4,8 and 12 h respectively. 
 
The result of a proliferation assay is shown in  
Fig. 16. Herein apoptosis was induced in HeLa cells with 1 µM Actinomycin D or 
50 µM Puromycin for indicated time points. The experiments shown in Fig. 15 and  
Fig. 16 were done at the same time on parallel plates. Thus a similar decline in 
viability should be observed (cyan and blue bars). But this is not the case in  
Fig. 16 in Actinomycin D-induced apoptosis (cyan bars). Here the signal remains 
nearly on the same level. In Puromycin-induced apoptosis a decrease of the signal 
could be observed (blue bars). This might reflect different mechanisms of apoptosis 
induction. For control cells were treated with PDTC, DMSO or left untreated (mock). 
Here no decline of viability was seen.  
A protective effect of PDTC could only be observed in Puromycin-induced apoptosis 
after 12 h. In this case the viability of Puromycin-PDTC co-treated cells was as high 
as those of untreated cells. 
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Further it is important to mention that PDTC reacts with the assay reagent. It was 
observed that blanks (= medium + treatment) containing PDTC change the colour 
from yellow to light brown during assay development (not shown). To eliminate this 
background, blanks were subtracted from each sample. 
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Fig. 16: Proliferation assay of HeLa cells treated as described in Fig. 15. 
 
 
A hallmark of apoptosis is the activation of caspases. Thus caspase activity should 
increase during apoptosis induction whereas viability decreases. To confirm previous 
results the caspase-3/7 activity was measured by using Caspase-Glo(R) 3/7 Assay 
(Promega). This assay is based on the cleavage of an artificial substrate by caspase-
3 and -7 subsequently providing a substrate for the luciferase. The measured 
luminescence is proportional to caspase activity. Caspase-3 and -7 are executioner 
caspases and activated at the end of the cascade leading to the characteristic 
pattern of apoptotic cells.  
 
Caspase 3/7 activity in Actinomycin D- and Puromycin-induced cell death is shown in 
Fig. 17. HeLa cells were treated again with 1 µM Actinomycin D or 50 µM Puromycin 
+/- 125 µM PDTC for indicated time points. For control cells were treated with PDTC, 
DMSO or left untreated (mock). In these cases no significant differences in caspase-
3/7 activity were observed. The activity of the executioner caspases-3 and -7 
increases in a time dependent manner when apoptosis is induced with Actinomycin D 
or Puromycin (cyan and blue bars). PDTC co-treated cells show less caspase-3/7 
activity (cyan- and blue-striated bars). 
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Fig. 17: Caspase 3/7 activity of Actinomycin D- and Puromycin-induced apoptosis in HeLa cells. Cells 
were treated as in Fig. 15. 
 
 
The results shown in the previous figures demonstrate that PDTC has a clear 
protective effect against apoptosis in HeLa cells. This is shown by microscopic 
observations (Fig. 13 and Fig. 14), a crystal violet assay which measures the amount 
of attached cells on the culture dish (Fig. 15) as well as by the activation of caspase-
3/7 (Fig. 17). 
If PDTC is present during induction of apoptosis more cells are attached on the 
surface and seem to be morphological intact (Fig. 13; Fig. 14; Fig. 15). Further the 
activity of executioner caspases-3 and -7 are reduced in the presence of PDTC (Fig. 
17). This effect is independent of the induction of apoptosis by Actinomycin D or 
Puromycin. 
Interestingly the protective effect of PDTC could only be observed in a proliferation 
assay in Puromycin-induced apoptosis after 12 h (Fig. 16). This assay is based on 
the activity of dehydrogenase enzymes of living cells. As shown in Fig. 16 the viability 
did not decrease in a time dependent manner after induction of apoptosis. The 
second problem by using this assay is that PDTC seems to react with the assay 
reagent. To eliminate the background blanks (=medium+treatment) were subtracted. 
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IV.2 The anti-apoptotic effect of PDTC depends on the 
presence of metal ions 
 
The presence of metal ions especially copper and zinc are described to be 
fundamental for PDTC to develop its function. For example it is described that EDTA 
is able to counteract PDTC thus abolishing its anti-viral activity against picornaviruses 
(Lanke, Krenn et al. 2007). 
To investigate if EDTA is also able to eliminate the anti-apoptotic effect of PDTC a 
crystal violet staining was done. HeLa cells were seeded on 12 well dishes and 
apoptosis induced with 50 µM Puromycin or 1 µM Actinomycin D +/- PDTC. In the 
case of Actinomycin D-induced apoptosis DMSO was used as vehicle control. 
Different concentrations of EDTA were added to desired wells as indicated in Fig. 18. 
After 10 h the cells were washed once with PBS and stained with crystal violet. This 
time point was chosen to see significant differences between apoptotic cells and cells 
which are protected by PDTC. 
 
 
                      
 
 
 
Fig. 18: Crystal violet staining of HeLa cells. Cells were treated with 1 µM Actinomycin D or 50 µM 
Puromycin +/- 125 µM PDTC as well as indicated concentrations of EDTA for 10 h. 
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Fig. 18 shows that EDTA can abolish the anti-apoptotic effect of PDTC in HeLa cells. 
In the upper part of Fig. 18 HeLa cells were treated with Actinomycin D +/- 125 µM 
PDTC and indicated concentrations of EDTA for 10 h. For control HeLa cells were 
treated with PDTC, DMSO as vehicle control as well as varied concentrations of 
EDTA. In the absence of EDTA the protective effect of PDTC is clearly visible. The 
presence of 25 µM EDTA abolished the majority of the anti-apoptotic effect. At higher 
concentrations of EDTA no protective effect of PDTC was observed anymore. 
The same experiment with Puromycin as apoptotic inducer is shown in the lower part 
of Fig. 18. Here apoptosis was induced with 50 µM Puromycin +/- 125 µM PDTC. 
Desired concentrations of EDTA were added and cells were incubated for 10 h. 
PDTC/EDTA treated cells serve as negative control. Again the protective effect of 
PDTC in Puromycin-induced is clearly visible if EDTA is absent. Addition of 25 µM 
EDTA abolished this effect completely after 10 h. 
 
 
 
The result shown in Fig. 18 clearly demonstrates that the presence of metal ions in 
the medium is a prerequisite for the anti-apoptotic effect of PDTC. 
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IV.3 Effects of PDTC on the intrinsic pathway of apoptosis 
 
To analyse the pathway in more detail subcellular fractionation was done. This 
method was chosen to analyse the release of cytochrome c from mitochondria and to 
investigate other apoptotic marker as described below. Therefore HeLa cells were 
seeded in 15 cm dishes, treated with 1 µM Actinomycin D or 50 µM Puromycin +/- 
125 µM PDTC as described in materials and methods. After different time points cells 
were disrupted and separated by centrifugation into three fractions (“mitochondria”, 
“cytosol”, “nucleus”). Hallmarks of apoptosis of each fraction were analysed by 
western blotting: 
 
Cytochrome c release: 
During apoptosis cyt c disappears from the mitochondria and appears in the 
cytosol. COX IV (cytochrome c oxidase IV) was used as mitochondrial loading 
control in western blot analysis. The purity of the cytosolic fraction i.e. the 
absence of mitochondria was also determined by COX IV as mitochondrial 
marker (not shown). 
 
Cleaved caspase 9: 
Cyt c which is released into the cytosol forms together with Apaf 1 and 
caspase 9 a complex called the Apoptosome. Subsequently caspase 9 is 
cleaved and activated. The appearance of a 37 kDa cleavage product of 
caspase-9 in the cytosol was analysed. 
 
PARP cleavage: 
PARP is located in the nucleus and cleaved as a consequence of caspase 3 
activity. Subsequently an 87 kDa cleavage product of PARP can be detected. 
 
To analyse small proteins like cyt c (15 kDa), COX IV (17 kDa) or cleaved caspase 9 
(37 kDa) a tricine PAGE was used. To analyse PARP cleavage protein samples were 
subjected to a 7,5 % acrylamide SDS PAGE as described in material and methods. 
Apoptotic markers were analysed by western blotting. 
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Fig. 19 shows the result of the fractionation of Actinomycin D-induced HeLa cells co-
treated +/- PDTC. The concentrations used are the same as described in Fig. 15. 
Cells were analysed after 6, 8 and 10 h. The amount of cytochrome c in mitochondria 
did not decrease in a significant way when apoptosis is induced with Actinomycin D. 
For control cells were treated with PDTC or DMSO as vehicle control. Neither PDTC 
nor DMSO leads to the release of cytochrome c. When PDTC is present during 
induction of apoptosis no big differences regarding the amount of cytochrome c in the 
mitochondria were observed. 
On the other hand cytochrome c appears in the cytosolic fraction when it is released. 
After 6 h p.t. cytochrome c can be detected in the cytosol of Actinomycin D-induced 
HeLa cells (Fig. 19, “Cytosol”). The amount of released cytochrome c seems to be 
constant at later time points.  
If HeLa cells were treated with Actinomycin D and PDTC, after 6 h no cytochrome c 
was detected in the cytosolic fraction. Two hours later (8 h p.t.) a slight band 
appeared when cells are co-treated with Actinomycin D + PDTC. After 10 h p.t. 
nearly the same amount of cytochrome c is released into the cytosol independent of 
the presence of PDTC during induction of apoptosis. 
 
In the case of Actinomycin D treated cells, the release of cytochrome c correlates 
well with the appearance of the 37 kDa cleavage product of cleaved caspase 9. It 
can be detected after 6 and 8 h p.t. and disappears at 10 h. PDTC and DMSO 
treated cells which serve as negative control did not show caspase-9 processing. 
Interestingly no caspase-9 processing could be detected in Actinomycin D + PDTC 
treated cells, despite the release of cytochrome c (Fig. 19). 
 
PARP cleavage was analysed to monitor the progress of apoptosis. PARP is cleaved 
as a consequence of caspase-3 activity late in the apoptotic program. PDTC or 
vehicle treated cells (DMSO) show no PARP cleavage. The cleavage product is 
observed after 6 h p.t. if cells are induced with Actinomycin D alone and increases in 
a time dependent manner. PDTC co-treatment reduces the the level of cleaved 
PARP after 8 and 10 h. This experiment was done twice revealing similar results. 
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Fig. 19: Subcellular fractionation of Actinomycin D-induced HeLa cells. Treatment as described in 
Fig. 15. Abbreviations: +/- with/without PDTC, P PDTC only, m mock(DMSO treated) 
 
The experiment shown in Fig. 19 demonstrates that PDTC delays cytochrome c 
release in Actinomycin D-induced apoptosis in HeLa cells. The absence of cleaved 
caspase 9 in PDTC co-treated cells but the appearance of cytochrome c in the 
cytosol could indicate a separate effect on the apoptosome-formation. 
 
 
The same experiment as shown in Fig. 19 was done with Puromycin to confirm the 
previous result. Again, apoptosis was induced in HeLa cells with Puromycin in the 
absence or presence of PDTC (Fig. 20). After indicated time points, subcellular 
fractionation was done as described in materials and methods. 
When apoptosis is induced the amount of cytochrome c in the mitochondrial fraction 
decreases in a time dependent manner and cannot be detected anymore at 7 h p.t 
(Fig. 20). In contrast, a decrease in the mitochondrial cytochrome c level was not 
observed in Actinomycin D-induced apoptosis (Fig. 19). 
PDTC or untreated cells (mock) which serve as negative control show an equal level 
of cytochrome c in the mitochondrial fraction (Fig. 20). This means that PDTC did not 
trigger cytochrome c release in our model system. 
In the presence of PDTC during Puromycin-induced apoptosis more cytochrome c is 
found in the mitochondria. 
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In the cytosolic fraction cytochrome c appears after 4-5 h p.t. Again PDTC and 
untreated cells show no cytochrome c release. If PDTC is present during Puromycin-
induced apoptosis the release of cytochrome c is delayed and can be detected at 
5 h p.t.. In general less cytochrome c is released when cells are co-treated with 
PDTC. These findings correlate well with the situation in the mitochondrial fraction. 
Cleaved caspase-9 is detected in Puromycin-induced HeLa cells after 3 h. If cells are 
co-treated with Puromycin and PDTC the cleavage product appears at 4 h p.t.. 
Cleaved PARP is detected after 4 h in cells treated with Puromycin alone. In the 
presence of PDTC the cleavage product is absent at this time point. At further time 
points only a weak band of the cleavage product is obtained when cells are co-
treated with PDTC. 
 
 
Fig. 20: Subcellular fractionation of Puromycin-induced HeLa cells +/- PDTC. Treatment as described 
in Fig. 15. Abbreviations: +/- with/without PDTC, P PDTC only, m mock 
 
The western blots shown in Fig. 20 demonstrate that PDTC affects cytochrome c 
release in Puromycin-induced apoptosis in HeLa cells. Less cytochrome c is released 
when cells are co-treated with PDTC. Subsequently less caspase 9 and PARP is 
cleaved. 
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IV.4 Effects of PDTC on caspase-9 processing and 
caspase-3 activity in a cell-free system 
 
In Fig. 19 it is shown that in Actinomycin D-induced apoptosis in HeLa cells the 
release of cytochrome c is delayed in the presence of PDTC. But no cleaved 
caspase 9 was detected. A similar situation is observed in Puromycin-induced 
apoptosis shown in Fig. 20. 
To analyse if the effects of PDTC on caspase 9 processing and PARP cleavage are 
consequences of previous effects on cytochrome c release or separate ones, a cell-
free system was used similar to those published (Liu, Kim et al. 1996). Apoptosis was 
induced in this system by addition of cytochrome c and (d)ATP. The principle of the 
assay is depicted in Fig. 21. 
 
Fig. 21: Shematic diagram of the cell-free system. Cytosolic 
extract and nuclei were prepared from untreated HeLa S3 
cells. Apoptosis was induced by addition of cytochrome c 
(cyt c) and (d)ATP in the absence 2) or presence of PDTC 
3). In 1) apoptosis was not induced (control). A cytosolic 
extract of PDTC-treated HeLa S3 was prepared and 
apoptosis induced 4). 
Fig. 22: Apoptotic events taking place 
in the presence of cytochrome c. Apaf-
1, cytochrome c and (d)ATP form the 
apoptosome which leads to the 
recruitment of procaspase-9. Active 
(processed) caspase-9 activates 
caspase-3. Further different cellular 
substrates are cleaved (e.g. PARP). 
 
 
Two 15 cm dishes of HeLa S3 were used. One dish was pre-treated with 125 µM 
PDTC for 1h. The reason to do so was the question if a metabolic processing of 
PDTC could influence apoptosis. The second dish was incubated with fresh growth 
medium for the same time. Cells were harvested and nuclei and cytosolic fractions 
prepared as described in materials and methods (Fig. 21). 
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Nuclei from untreated cells were mixed either with the cytosolic fraction of PDTC-
treated cells (Fig. 21 4)) or with the cytosolic fraction of untreated cells (Fig. 21 1-3)). 
To one reaction containing the cytosol of untreated cells 125 µM PDTC was added 
(Fig. 21 3)).  
After induction of apoptosis by addition of cytochrome c and dATP/ATP reactions 
were incubated at 37°C. The events which are taking place in the cell-free system 
are depicted in Fig. 22. The addition of cytochrome c and dATP/ATP leads to the 
formation of the apoptosome. Subsequently caspase-9 is processed leading to 
activation of caspase-3. Finally PARP is cleaved as a consequence of caspase-3 
activity. At different time points an aliquot was taken and 4x sample buffer added to 
stop the reaction. Processing of caspase-9 and PARP cleavage was determined by 
western blotting. 
 
Fig. 23 shows the result of such an experiment. The negative control (i.e. no 
apoptosis induced; Fig. 21 1)) is shown in lanes A1, A5, B1 and B5. In this reaction 
cytochrome c is missing thus no apoptotic event should occur at any time point. This 
control is necessary to ensure that no unspecific degradation of caspase-9 or PARP 
occurs. Only a very small amount of caspase-9 and PARP was cleaved without 
induction of apoptosis after 180 min (lane B5). 
The positive control (i.e. induction of apoptosis) is shown in lanes A3, A7, B3 and B7. 
In this reaction all apoptotic events as depicted in Fig. 22 should take place. When 
apoptosis was induced by addition of cytochrome c and dATP/ATP, cleaved 
caspase-9 was detected after 60 min (lane A7). The level of cleaved caspase-9 
increases in a time dependent manner (lane B3 and B7). 
PARP cleavage correlates well with caspase 9 processing (lanes A3, A7, B3 and B7). 
The cleavage product of PARP appears after 30 min of incubation and increases in a 
time dependent manner. After 180 min of incubation approximately 90 percent of 
PARP are cleaved (lane B7).  
If PDTC was added to the cell-free system (Fig. 23 lanes A4, A8, B4 and B8; Fig. 21 
3)) no anti-apoptotic effect was observed at any time point. Caspase-9 processing 
and PARP cleavage occurred with same rate as in the positive control (lanes A3, A7, 
B3 and B7). 
If the cytosolic fraction of PDTC-treated cells was used and apoptosis induced by 
addition of cytochrome c + dATP/ATP (Fig. 23 lanes A2, A6, B2 and B6; Fig. 21 4)), 
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an anti-apoptotic effect was observed. After 60 min nearly no caspase-9 was 
processed (lane A6) compared to the positive control in lane A7. This effect was 
continued at later time points. Caspase-9 processing was inhibited at 120 and 
180 min after induction of apoptosis (lanes B2 and B6). These findings correlate well 
with the cleavage of PARP. Less PARP was cleaved at all time points when the 
cytosolic fraction of PDTC-treated cells was used (lanes A2, A6, B2 and B6) 
compared to the positive control (lanes A3, A7, B3 and B7). 
Actin was used here as loading control. This experiment was done twice revealing 
similar results. 
 
 
 
 
Fig. 23: Apoptosis in HeLa S3 cell free extracts. Apoptosis was induced by the addition of dATP/ATP 
and cytochrome c. Cell extracts of PDTC pre-incubated or untreated cells were used. PDTC was 
added as indicated. Caspase 9 processing and PARP cleavage were analysed at different time 
points. 
Abbreviations: cl. Cas9: cleaved caspase 9; cp: cleavage product; pre: cytosolic extract of PDTC pre-
incubated cells; 
 
 
The result shown in Fig. 23 demonstrates that PDTC has no anti-apoptotic effect 
when apoptosis was induced in the cell-free system. In contrast, if apoptosis was 
induced using a cytosolic extract of PDTC-treated HeLa S3 cells, anti-apoptotic 
effects were observed. This means that an interaction between PDTC and living cells 
is the prerequisite revealing its anti-apoptotic activity. 
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IV.5 Effects of PDTC on caspase-3 
 
Previously it was described that caspases could be inhibited by zinc ions (Truong-
Tran, Carter et al. 2001). It was also demonstrated that PDTC increases intracellular 
zinc (Lanke, Krenn et al. 2007). This could be the reason for the anti-apoptotic effect 
of PDTC. 
To check if PDTC acts on caspase 3 directly, the caspase 3-overexpressing cell line 
MCF-7-cas3+ was used. As control MCF-7 cells were used which lack a functional 
caspase-3 gene. It was analysed if PDTC is able to inhibit apoptosis in these cell 
lines. 
 
 
IV.5.1 Effects of PDTC on Puromycin-induced cell death in MCF-7 
and MCF-7-cas3+ 
 
To induce apoptosis MCF-7 cells and caspase 3-overexpressing MCF-7-cas3+ cells 
were treated with 50 µM Puromycin +/- 125 µM PDTC. Puromycin was chosen 
because of its well known mode of action. Viability of both cell lines under these 
conditions was checked visually as well by proliferation- and crystal violet assay. 
 
The pictures showed in Fig. 24 are typical microscopic observation of MCF-7 cells 
undergoing Puromycin-induced apoptosis. After 4 h of induction approximately 30 
percent of cells showed typical morphological properties of apoptosis. The fraction of 
apoptotic cells increases dramatically in a time dependent manner. 8 h p.t. 
approximately 70 percent of Puromycin-treated cells are rounded up. After 12 h 
nearly all cells are dead and floating. 
In contrast, if PDTC is present during Puromycin-induced apoptosis the cells are 
protected. About 20 percent of MCF-7cells are rounded up at any time point when co-
treated with Puromycin and PDTC. 
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Fig. 24: MCF-7 cells treated with 50 µM Puromycin +/- 125 µM PDTC 
 
 
In Fig. 25 MCF-7-cas3+ cells undergoing Puromycin-induced apoptosis are shown. 
After 4 h of induction of apoptosis about 30 percent of the cells are rounded up. This 
value increases to approximately 70 percent after 8 h. Finally after 12 h near all cells 
show an apoptotic morphology. In the presence of PDTC after 4 and 8 h about 10-20 
percent of the cells are dead. Approximately 30 percent of round cells are found after 
12 h when PDTC is present during Puromycin-induced apoptosis. This finding is 
similar to those obtained from caspase-3 deficient MCF-7 cells (Fig. 23). 
 
 
 
 
 
mock 
4 h p.t. 
Puro Puro + PDTC
8 h p.t. 
12 h p.t. 
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Fig. 25: MCF-7-cas3+ cells treated with 50 µM Puromycin +/- 125 µM PDTC 
 
The pictures shown in Fig. 24 and Fig. 25 demonstrate that PDTC has anti-apoptotic 
properties in MCF-7 and MCF-7-cas3+ cells. In both cell lines PDTC prevents the 
development of characteristic morphological features of Puromycin-induced 
apoptosis. 
 
mock Puro Puro + PDTC
4 h p.t. 
8 h p.t. 
12 h p.t. 
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To quantify the observed effect of PDTC in MCF-7 cells a proliferation- and crystal-
violet assay was done. Fig. 26 shows the results of these assays. Both cell lines 
MCF-7 and caspase-3 overexpressing MCF-7-cas3+ were treated with 50 µm 
Puromycin +/- 125 µM PDTC for indicated time points. Proliferation assay and crystal 
violet staining were done on parallel plates. 
In both cell lines Puromycin reduces viability slightly when measured by proliferation 
assay (blue bars). For control cells were left untreated (mock). When PDTC was 
present (striated bars) the signal increases strongly and reaches a value above of 
untreated cells. To ensure that this effect is not due to the interference between 
PDTC and the assay reagent, blanks (= medium + treatment) were subtracted. 
The crystal violet assays shown in the lower panel in Fig. 26 correlate well with the 
observed morphological changes of both cell lines due to Puromycin-treatment (see 
Fig. 24 and Fig. 25 for comparison). The signal which reflects the amount of attached 
cells decreases in both cell lines in a time dependent manner. This represents 
apoptotic cells which are washed away during the staining procedure. Again cells 
were treated with PDTC alone or left untreated as control. PDTC alone did not cause 
significant reduction of the signal in MCF-7 cells (Fig. 26 lower left panel) and 
showed no effect in MCF-7-cas3+ cells (Fig. 26 lower right panel). 
As depicted in Fig. 24 and Fig. 25, PDTC shows a protective effect on Puromycin-
induced cell death in MCF-7 and MCF-7-cas3+ cells (Fig. 26 lower panel, blue-black 
striated bars).  
This experiment was done twice and similar results were obtained. 
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Fig. 26: Proliferation assay and crystal violet staining of MCF-7 and MCF-7-cas3+ cells. Cells were 
treated with 50 µM Puromycin +/- 125 µM PDTC. Experiment done on parallel plates. 
 
The results shown in Figures 24-26 demonstrate a protective effect of PDTC on 
Puromycin-induced cell death in MCF-7 and MCF-7-cas3+ cells. This can be seen 
clearly in microscopic observations and crystal violet staining. In contrast, the 
proliferation assay which is based on the activity of dehydrogenase enzymes of living 
cells did not reveal a distinct result. 
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IV.5.2 Effects of PDTC on early- and late phase of apoptosis 
 
One aim of this project was to investigate if PDTC acts on caspase-3 directly. Thus 
caspase-3 overexpressing MCF-7-cas3+ cells and caspase-3 deficient MCF-7 cells 
were used. PDTC exhibits a protective effect against Puromycin-induced apoptosis in 
both cell lines as shown in Fig. 24-26. This means that caspase-3 can not be the only 
target of PDTC. 
However, it is described that caspase inhibitors can change the kind of cell death 
(Vandenabeele, Vanden Berghe et al. 2006). Thus a rhodamine/propidium iodide 
staining was done which allows the discrimination between an early phase of 
apoptosis and a late phase of apoptosis / necrosis. 
Rhodamine (R123) is a lipophilic cationic fluorochrome which accumulates in the 
mitochondria of living cells. In early apoptotic cells this accumulation does not occur 
due to loss of mitochondrial transmembrane potential (Fig. 27, gate R1). Late 
apoptotic/necrotic cells stain only with propidium iodide (PI) due to the loss of plasma 
membrane integrity (Fig. 27, gate R2). 
To analyse if PDTC acts on caspase-3 directly, apoptosis was induced in MCF-7 and 
MCF-7-cas3+ cells with 50 µM Puromycin +/- 125 µM PDTC for 8 h. This time point 
was chosen due to low differences between Puromycin and Puromycin+PDTC 
treated cells at previous time points. After treatment MCF-7 and MCF-7-cas3+ cells 
were harvested by trypsinization and subjected to R123/PI staining. For control cells 
were also treated with PDTC alone or left untreated. Cell fluorescence was analyzed 
by flow cytometry after 8 h p.t. as described in materials and methods. The results of 
such an experiment are shown in Fig. 27 and Fig. 28. 
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When cell death is induced with Puromycin, both cell lines show a different pattern of 
apoptosis. Eight hours after induction of apoptosis approximately 4 % of MCF-7 cells 
are found in the early phase and 30 % are found in the late phase of apoptosis (Fig. 
28). In contrast, in caspase 3-overexpressing MCF-7-cas3+ cells approximately 7 % 
are found in the early phase of apoptosis and approximately 13 % in the late phase 
(Fig. 28). 
 
But when both cell lines were treated with Puromycin + PDTC the pattern looks 
nearly the same after 8 h (Fig. 27). If the anti-apoptotic effect of PDTC depends 
mainly on the inhibition of caspase-3, the distribution of caspase-3 deficient MCF-7 
cells between early- and late phase of apoptosis should be unaffected when treated 
with Puromycin + PDTC. Further, if caspase-3 is the main target of PDTC, the 
distribution of MCF-7-cas3+ cells between early- and late phase of apoptosis should 
look similar to the pattern of MCF-7 cells, when PDTC is present during induction of 
apoptosis. 
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Fig. 28: Quantification of R123/PI staining. Percentage of cells found in gate R1 (early phase) or gate 
R2 (late phase) in Fig. 27. 
 
 
The results shown in Fig. 27 and Fig. 28 demonstrate that PDTC does not act mainly 
on caspase-3. Thus caspase-3 is not the major target of PDTC. 
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IV.6 Effects of PDTC on the PI3K/Akt pathway 
 
In the literature it is described that PDTC can increase the intracellular concentration 
of zinc (Lanke, Krenn et al. 2007). Further it is described that the PI3K/Akt pathway 
can be activated by Zn2+, Cu2+ and Cd2+ ions. In this case the phosphorylation of Akt 
occurred in a PI3K-dependent manner. This was concluded by the fact that the 
phosphorylation of Akt was abolished by the presence of wortmannin, a PI3K inhibitor 
(Barthel, Ostrakhovitch et al. 2007). Not surprisingly there are two reports concerning 
the phosphorylation of Akt due to PDTC treatment. In one study it is shown that 
PDTC leads to phosphorylation of Akt only when apoptosis is induced (Cheng, 
Huang et al. 2006). In contrast PDTC alone was not able to activate Akt (Cheng, 
Huang et al. 2006). 
 
However, the idea emerged that the activation of the PI3K/Akt pathway could be the 
major reason for the anti-apoptotic effect of PDTC. First of all it was investigated if 
PDTC was able to induce the phosphorylation of Akt and if this event is based on the 
activity of PI3K. 
Therefore HeLa cells were pre-incubated with 1 µM wortmannin, a PI3K inhibitor, or 
an appropriate volume of DMSO as vehicle control for one hour. Afterwards cells 
were treated with 125 µM PDTC in the presence or absence of 1 µM wortmannin for 
different time points. DMSO was added to all samples which did not contain 
wortmannin. Activation of Akt was determined by western blotting using a specific 
antibody against pAkt (Ser473). The membrane was stripped afterwards and probed 
with an antibody against total Akt as loading control.  
The result of such an experiment is shown in Fig. 29. In lanes 1,4 and 7 HeLa cells 
were incubated with growth medium and DMSO which serves as solvent control. 
Only after 60 min a weak phosphorylation of Akt could be detected under these 
conditions (lane 7). If PDTC (and DMSO) was present a phosphorylation could be 
detected after 20, 40 and 60 min of incubation (lanes 2,5,8). If PI3K was inhibited by 
wortmannin no Akt phosphorylation could be observed in the presence of PDTC 
(lanes 3,6,9). This experiment was done three times obtaining similar results. 
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Fig. 29: PDTC-induced phosphorylation of Akt (Ser473) 
 
The result in Fig. 29 demonstrates that PDTC is able to induce the phosphorylation of 
Akt. Further it is shown that PI3K activity is a prerequisite for PDTC-induced Akt 
phosphorylation. 
 
 
The Akt pathway provides survival signals for the cell and is able to inhibit apoptosis. 
These signalling events can be prevented by the inhibition of PI3K by wortmannin. If 
the activation of Akt by PDTC is the reason for its anti-apoptotic activity, wortmannin 
should abolish the anti-apoptotic effect of PDTC.  
 
To answer this question HeLa cells were pre-incubated with 1 µM wortmannin or an 
appropriate volume of DMSO as vehicle control for one hour. Apoptosis was induced 
with 1 µM Actinomycin D or 50 µM Puromycin. Cells were incubated with the inducer 
in presence or absence of PDTC +/- 1 µM wortmannin. DMSO as vehicle control was 
added to all samples which did not contain wortmannin. After 4 and 8 h p.t. protein 
extracts were prepared. PARP cleavage was determined by western blotting to 
determine apoptosis. Actin was detected on the same blot as loading control. The 
result of such an experiment is shown in Fig. 30 and Fig. 31. 
In Fig. 30 apoptosis was induced with Actinomycin D. After 4 h p.t. no effect could be 
observed (Fig. 30, lanes 1-3). After 8 h p.t. PARP cleavage was detected when 
apoptosis was induced (lane 4). If cells were co-treated with PDTC no PARP 
cleavage was seen (lane 5). As control cells were treated with wortmannin alone 
(lane 7) or only with DMSO (lane 8). No PARP cleavage was detected in these 
cases. 
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When apoptosis was induced with Actinomycin D in the presence of PDTC and 
wortmannin, only a small amount of cleaved PARP was observed (lane 6). This 
means that the activation of the PI3K/Akt pathway seems not to be the major reason 
for the anti-apoptotic activity of PDTC. 
 
 
 
Fig. 30: Wortmannin vs. PDTC in Actinomycin D-induced apoptosis in HeLa cells. 
 
In Puromycin-induced apoptosis a similar situation was observed as shown in Fig. 
31. Again HeLa cells were treated with the inducer in presence or absence of PDTC 
+/- wortmannin. After 4 h no significant effect was observed. After eight hours PARP 
was cleaved nearly completely when apoptosis was induced by Puromycin (Fig. 31, 
lane 4). In the presence of PDTC approximately fifty percent of PARP were cleaved 
(lane 5). If the cells were co-treated with Puromycin, PDTC and wortmannin, PARP 
cleavage was about fifty percent after 8 h (Fig. 31, lane 6). For control cells were 
treated with wortmannin alone or with DMSO as vehicle control. Herein no PARP 
cleavage could be detected (lanes 7 and 8). 
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Fig. 31: Wortmannin vs. PDTC in Puromycin-induced apoptosis in HeLa cells. 
 
The results shown in Fig. 30 and Fig. 31 demonstrate that the PI3K inhibitor 
wortmannin can not counteract PDTC in regard to Actinomycin D and Puromycin-
induced apoptosis in HeLa cells. This means that PDTC-induced activation of the 
PI3K/Akt pathway (Fig. 29) is not the main reason for the anti-apoptotic activity of 
PDTC.  
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Discussion 
 
The effects of PDTC (Pyrrolidine dithiocarbamate) described in the literature range 
from pro-apoptotic, anti-apoptotic, inhibition of picornaviruses, inhibition of the 
proteasome as well as inhibition of NFκB (Kim, Kim et al. 1999; Della Ragione, 
Cucciolla et al. 2000; Erl, Weber et al. 2000; Kim, Kim et al. 2004; Cheng, Huang et 
al. 2006; Lanke, Krenn et al. 2007). In most cases the activity of PDTC described 
depends on the presence of metal ions especially zinc and copper. 
The aim of this project was to investigate the mode of action of PDTC regarding 
apoptosis. Due to the fact that PDTC is able to increase the intracellular 
concentration of zinc (Lanke, Krenn et al. 2007), and that zinc ions may affect 
apoptosis (Truong-Tran, Carter et al. 2001), two scenarios were assumed: 
 
First the increase of intracellular zinc could inhibit caspase-3 activity by interfering 
with the active center as described (Truong-Tran, Carter et al. 2001). 
 
Secondly the increase of intracellular zinc could trigger a survival signal thus 
inhibiting apoptosis. One possibility is the activation of the PI3K/Akt pathway. It was 
described that zinc ions are able to activate this pathway and there are also two 
papers concerning the phosphorylation of Akt due to PDTC treatment (Cheng, Huang 
et al. 2006; Barthel, Ostrakhovitch et al. 2007; Malm, Iivonen et al. 2007). 
 
In this project it is shown that PDTC exhibit an anti-apoptotic effect in Actinomycin D- 
and Puromycin-induced apoptosis in HeLa cells. Further an inhibitory effect was also 
observed in Puromycin-induced apoptosis in caspase-3 deficient MCF-7 and 
caspase-3 overexpressing MCF-7-cas3+ cells. 
It is shown that the anti-apoptotic effect of PDTC depends on metal ions. This is 
because EDTA, which chelates divalent cations, can counteract PDTC. 
The release of cytochrome c, a hallmark of apoptosis is delayed in the presence of 
PDTC in Actinomycin D- as well as in Puromycin-induced apoptosis. Processing of 
caspase-9 was not observed in Actinomycin D-induced apoptosis in HeLa cells even 
if cytochrome c was released. 
In a cell-free system the effects of PDTC on caspase-9 and caspase-3 were 
investigated. PDTC exhibit no anti-apoptotic effect in this system when apoptosis was 
 81
induced by the addition of cytochrome c and (d)ATP. In contrast, if apoptosis was 
induced using cytosolic extracts of PDTC-treated cells, a weak inhibitory effect of 
PDTC was observed.  
PDTC was also able to inhibit Puromycin-induced apoptosis in caspase-3 deficient 
MCF-7 as well as in caspase-3 overexpressing MCF-7-cas3+ cells. 
Further it is demonstrated that in our system PDTC leads to rapid activation of the 
PI3K/Akt pathway, which can influence apoptosis. Surprisingly inhibition of this 
pathway did not abolish the anti-apoptotic effect of PDTC. 
 
 
V.1 The anti-apoptotic effect of PDTC 
 
It is reported in the literature that apoptosis can be inhibited as well as induced by 
PDTC (Nobel, Burgess et al. 1997; Della Ragione, Cucciolla et al. 2000; Erl, Weber 
et al. 2000; Cheng, Huang et al. 2006). The latter effect of PDTC depends on cell 
type, cell density and on the presence of zinc and copper (Erl, Weber et al. 2000). 
In this study PDTC exhibit a protective effect against Actinomycin D- and Puromycin-
induced apoptosis in HeLa cells. Such an effect was also observed in caspase-3 
deficient MCF-7 and caspase-3 overexpressing MCF-7-cas3+ cells when apoptosis 
was induced with Puromycin. These findings would suggest a common mechanism of 
PDTC. Regarding effects of PDTC on apoptosis described in the literature and 
compared with the results of this project, the question raises why PDTC can act as 
apoptotic inducer as well as inhibitor. In other words: which criteria must be fullfilled 
to enable PDTC to act as an inhibitor of apoptosis? Answering this question seems to 
be important to reveal the mode of action of PDTC. 
In the literature it is described that zinc or copper ions are a prerequisite for PDTC to 
exhibit its biological activity (Kim, Kim et al. 1999; Erl, Weber et al. 2000; Kim, Kim et 
al. 2004; Lanke, Krenn et al. 2007).  
To check if the presence of metal ions is necessary for the anti-apoptotic effect of 
PDTC, EDTA should be able to counteract PDTC. In this study EDTA was able to 
abolish the anti-apoptotic effect in Actinomycin D- as well as in Puromycin-induced 
apoptosis in HeLa cells. This demonstrates that the presence of certain metal ions in 
the medium is necessary for PDTC to develop its function. It is likely that these ions 
are Zn2+ and Cu2+, because it is reported in several publications that zinc and copper 
ions are associated with the effect of PDTC (Kim, Kim et al. 1999; Erl, Weber et al. 
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2000; Kim, Kim et al. 2004; Krenn, Holzer et al. 2005). In the medium itself there are 
of course inorganic salts but no zinc or copper (Invitrogen). Thus the serum which is 
added to the medium seems to be the source of such ions. The concentration of zinc 
or copper ions in the serum used can not be indicated because this is not mentioned 
in the certificate of analysis or in any other product description. The concentration of 
zinc in calf serum is about 76 µg/dl (Nisbet, Yarim et al. 2006). 
However, EDTA is a metal chelating compound which forms complexes mainly with 
divalent cations. The resulting question is if zinc or copper ions are necessary for the 
anti-apoptotic effect of PDTC because EDTA does not only form complexes with 
these two ions. 
 
 
V.2 Effects of PDTC on cytochrome c release 
 
The release of cytochrome c from the mitochondria into the cytosol is a hallmark of 
apoptosis. In the literature it is mentioned that PDTC cause the release of 
cytochrome c from mitochondria in HL-60 cells (Della Ragione, Cucciolla et al. 2000; 
Cheng, Huang et al. 2006). Interestingly Ragione et al. describes PDTC as apoptotic 
inducer whereas Cheng et al. demonstrate an anti-apoptotic effect of PDTC in 
Luteolin-induced apoptosis, despite the release of cytochrome c due to PDTC-
treatment (Della Ragione, Cucciolla et al. 2000; Cheng, Huang et al. 2006). In 
Ragione et al. it is shown that incubation of purified mitochondria with PDTC alone 
lead to the release of cytochrome c. Thus it was concluded that the mitochondria are 
the primary targets of PDTC (Della Ragione, Cucciolla et al. 2000). 
Here in this project it is shown that PDTC delayed the release of cytochrome c in 
Actinomycin D- and Puromycin-induced apoptosis in HeLa cells. PDTC alone was 
unable to cause the release of cytochrome c in HeLa cells. This indicates a pre- 
and/or mitochondrial effect of PDTC. 
 
 
V.3 Effects of PDTC on caspases 
 
It is described in the literature that PDTC increases intracellular zinc levels (Krenn, 
Holzer et al. 2005; Lanke, Krenn et al. 2007). Truong-Tran et al. describe the effects 
of zinc on the activation of caspases especially on caspase-3 (Truong-Tran, Carter et 
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al. 2001). Thus it was assumed that the import of zinc by PDTC leads to the inhibition 
of caspases and therby contributing to the anti-apoptotic effect observed. 
In this project it is shown that the release of cytochrome c is delayed in the presence 
of PDTC in Actinomycin D- and Puromycin-induced apoptosis in HeLa cells. Further, 
in Actinomycin D-induced apoptosis caspase-9 is not processed (i.e. cleaved) even if 
cytochrome c is released (Fig. 19). This might be a consequence of delayed 
cytochrome c release or indicate an effect on caspase-9 processing. 
 
To investigate the effects of PDTC on caspase-9 processing in more detail, a cell-
free system was performed similar to those published (Liu, Kim et al. 1996). The 
advantage of such a system is that pre- and mitochondrial events of apoptosis are 
removed. This is because apoptosis is induced in the cell-free system by the addition 
of cytochrome c and (d)ATP. The cleavage of PARP was also analysed in this 
system and reflects the activity of caspase-3. In the presence of PDTC no anti-
apoptotic effect was observed regarding caspase-9 and PARP cleavage at any time 
point (Fig. 23). This finding suggests that neither caspase-9 nor caspase-3 is affected 
by PDTC directly. 
In Truong-Tran et al. it is mentioned that in cell-free systems PARP cleavage was 
inhibited in the presence of zinc (Truong-Tran, Carter et al. 2001). Thus the same 
experiment was done using a cytosolic extract of PDTC treated HeLa S3 cells. In this 
case a weak anti-apoptotic effect of PDTC on the processing of caspase-9 was 
observed. This result obtained from the cell-free system is similar to those 
determined in Actinomycin D-induced apoptosis in HeLa cells. This might be due to 
import of ions into the cells or due to metabolic processing of PDTC.  
The effects of PDTC on caspase-3 were also analysed by using the caspase-3 
deficient cell line MCF-7 as well as caspase-3 overexpressing cells (MCF-7-cas3+). It 
is described that apoptosis can occur in MCF-7 cells by sequential activation of 
caspase-9, -7 and -6 (Simstein, Burow et al. 2003). As seen in Fig. 24, Fig. 25, Fig. 
26 and Fig. 27 an anti-apoptotic effect of PDTC in Puromycin-induced apoptosis was 
observed in MCF-7 and MCF-7-cas3+ cells. These findings exclude caspase-3 as 
main target of PDTC. 
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V.4 PDTC-induced Akt phosphorylation has no effect on 
apoptosis in HeLa cells 
 
In the literature it is described that PDTC leads to the phosphorylation of Akt in 
Luteolin-induced apoptosis in HL-60 cells (Cheng, Huang et al. 2006). But PDTC 
alone failed to activate the PI3K/Akt pathway in this study. Further it is described that 
Akt is phosphorylated due to treatment of zinc in HeLa cells in a PI3K-dependent 
manner (Barthel, Ostrakhovitch et al. 2007). Hence the idea evolved that PDTC 
activates the PI3K/Akt pathway leading to survival signals. Fig. 29 demonstrates that 
PDTC cause the phosphorylation of Akt at Ser473 shortly after treatment in HeLa 
cells. This phosphorylation is abolished by the presence of wortmannin, which is a 
PI3K inhibitor. This finding means that the activity of PI3K is a prerequisite for PDTC-
induced Akt phosphorylation. A similar situation was observed for zinc-induced Akt 
phosphorylation in HeLa cells (Barthel, Ostrakhovitch et al. 2007). 
The wortmannin-sensitivity of PDTC-induced Akt phosphorylation was the 
requirement for the next experiment. If the activation of the PI3K/Akt pathway is the 
reason for the anti-apoptotic effect of PDTC, it should be abolished by wortmannin. 
Surprisingly this is not the case as shown in Fig. 30 and Fig. 31. Wortmannin failed to 
counteract PDTC after 8 h. 
 
 
V.5 Conclusions 
 
Taking together, these findings suggest that PDTC acts mainly at pre- and/or 
mitochondrial stages of apoptosis. It is demonstrated that PDTC delays the release of 
cytochrome c from the mitochondria which is a hallmark of apoptosis. An inhibitory 
effect of PDTC on caspase-9 processing is observed in Actinomycin D-induced 
apoptosis in HeLa cells and in the cell-free system. Further it is demonstrated that 
PDTC does not act mainly on caspase-3 as assumed at the beginning. 
Surprisingly the activation of Akt by PDTC which is known to inhibit apoptosis is not 
the reason for its anti-apoptotic activity. 
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V.6 Open questions and future experiments 
 
PDTC is able to inhibit the activation of NFκB (Kim, Kim et al. 1999). This 
ubiquitously expressed transcription factor is known to exhibit anti-apoptotic as well 
as pro-apoptotic effects (Shishodia and Aggarwal 2002). The function of NFκB 
regarding cell death depends on cell type and apoptotic stimuli. NFκB promotes cell 
survival due to inducing the transcription of anti-apoptotic genes such as members of 
the IAP or Bcl-2 family. Anti-apoptotic effects of NFκB are also mediated by down-
regulation of apoptotic genes. There are also findings which suggest that the anti-
apoptotic effects of this transcription factor are based on protein-protein interaction 
rather than de novo protein synthesis (Shishodia and Aggarwal 2002). 
In the case of Puromycin-induced apoptosis de novo protein synthesis can not occur 
due to inhibition by this inducer. If PDTC acts on NFκB, the anti-apoptotic effect can 
be mediated only by protein-protein interactions of NFκB. In this case NFκB must 
exhibit pro-apoptotic properties in Puromycin-induced apoptosis in HeLa and MCF-7 
cells. 
An important question is why PDTC exhibit pro- as well as anti-apoptotic properties. 
Certainly the different roles of NFκB as well as the fact that PDTC acts on this 
transcription factor could explain this observation. Provided the inhibition of NFκB by 
PDTC is the reason for the anti-apoptotic effect. 
 
The results of this project suggest a pre- and/or mitochondrial effect of PDTC. 
Ragione et al. also concluded that mitochondria are the primary targets of PDTC 
(Della Ragione, Cucciolla et al. 2000). In contrast to the results in this diploma thesis 
Ragione et al. describe PDTC as inducer of apoptosis in HL-60 cells (Della Ragione, 
Cucciolla et al. 2000). Different cellular models can also be the reason for the 
different effects of PDTC observed (Erl, Weber et al. 2000). 
To clearify if PDTC acts on the level of mitochondria, it should be investigated if 
PDTC is able to inhibit or to promote cytochrome c release of isolated mitochondria in 
vitro. Therefore cytochrome c release can be triggered by recombinant Bax protein or 
by the addition of calcium.  
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